<SEC-DOCUMENT>0001193125-24-006619.txt : 20240111
<SEC-HEADER>0001193125-24-006619.hdr.sgml : 20240111
<ACCEPTANCE-DATETIME>20240111162033
ACCESSION NUMBER:		0001193125-24-006619
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20240111
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240111
DATE AS OF CHANGE:		20240111

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			INTERNATIONAL FLAVORS & FRAGRANCES INC
		CENTRAL INDEX KEY:			0000051253
		STANDARD INDUSTRIAL CLASSIFICATION:	INDUSTRIAL ORGANIC CHEMICALS [2860]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				131432060
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-04858
		FILM NUMBER:		24529481

	BUSINESS ADDRESS:	
		STREET 1:		521 W 57TH ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019
		BUSINESS PHONE:		2127655500

	MAIL ADDRESS:	
		STREET 1:		521 W 57TH ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	VANAMERIGEN HAEBLER INC
		DATE OF NAME CHANGE:	19680426
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d712376d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iff="http://www.iff.com/20240111" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2024-01-11_to_2024-01-11">INTERNATIONAL FLAVORS &amp; FRAGRANCES INC</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey_duration_2024-01-11_to_2024-01-11" name="dei:EntityCentralIndexKey" contextRef="duration_2024-01-11_to_2024-01-11">0000051253</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_AmendmentFlag_duration_2024-01-11_to_2024-01-11" name="dei:AmendmentFlag" contextRef="duration_2024-01-11_to_2024-01-11">false</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="iff-20240111.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2024-01-11_to_2024-01-11"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-11</xbrli:startDate> <xbrli:endDate>2024-01-11</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2024-01-11_to_2024-01-11_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-11</xbrli:startDate> <xbrli:endDate>2024-01-11</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2024-01-11_to_2024-01-11_us-gaap-StatementClassOfStockAxis_iff-A1.750SeniorNotesDue2024Member"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">iff:A1.750SeniorNotesDue2024Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-11</xbrli:startDate> <xbrli:endDate>2024-01-11</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2024-01-11_to_2024-01-11_us-gaap-StatementClassOfStockAxis_iff-A1.800SeniorNotesDue2026Member"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">iff:A1.800SeniorNotesDue2026Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-11</xbrli:startDate> <xbrli:endDate>2024-01-11</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2024-01-11_to_2024-01-11_dei-EntityAddressesAddressTypeAxis_dei-OtherAddressMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000051253</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:OtherAddressMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-11</xbrli:startDate> <xbrli:endDate>2024-01-11</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p><p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p><p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p><p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p><p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"><p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div><p style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2024-01-11_to_2024-01-11" id="Fact_1">8-K</ix:nonNumeric></span></p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"><p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div><p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p><p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">PURSUANT TO SECTION 13 OR 15(D)</p><p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">OF THE SECURITIES EXCHANGE ACT OF 1934</p><p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2024-01-11_to_2024-01-11" format="ixt:date-monthname-day-year-en" id="Fact_0">January 11, 2024</ix:nonNumeric></p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"><p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div><p style="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName" id="Fact_2">INTERNATIONAL FLAVORS &amp; FRAGRANCES INC.</span></p><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"><p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric contextRef="duration_2024-01-11_to_2024-01-11" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen">New York</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric contextRef="duration_2024-01-11_to_2024-01-11" name="dei:EntityFileNumber">1-4858</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric contextRef="duration_2024-01-11_to_2024-01-11" name="dei:EntityTaxIdentificationNumber">13-1432060</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">file number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr> </table><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:48%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric contextRef="duration_2024-01-11_to_2024-01-11" name="dei:EntityAddressAddressLine1">521 West 57th Street</ix:nonNumeric></p><p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric contextRef="duration_2024-01-11_to_2024-01-11" name="dei:EntityAddressCityOrTown">New York</ix:nonNumeric>, <ix:nonNumeric contextRef="duration_2024-01-11_to_2024-01-11" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen">New York</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric contextRef="duration_2024-01-11_to_2024-01-11" name="dei:EntityAddressPostalZipCode">10019</ix:nonNumeric></span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2024-01-11_to_2024-01-11_dei-EntityAddressesAddressTypeAxis_dei-OtherAddressMember" id="Fact_3">200 Powder Mill Road</ix:nonNumeric></p><p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2024-01-11_to_2024-01-11_dei-EntityAddressesAddressTypeAxis_dei-OtherAddressMember" id="Fact_4">Wilmington</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2024-01-11_to_2024-01-11_dei-EntityAddressesAddressTypeAxis_dei-OtherAddressMember" format="ixt-sec:stateprovnameen" id="Fact_5">Delaware</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2024-01-11_to_2024-01-11_dei-EntityAddressesAddressTypeAxis_dei-OtherAddressMember" id="Fact_6">19803</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of Principal Executive Offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr> </table><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(<ix:nonNumeric contextRef="duration_2024-01-11_to_2024-01-11" name="dei:CityAreaCode">212</ix:nonNumeric>) <span style="white-space:nowrap"><ix:nonNumeric contextRef="duration_2024-01-11_to_2024-01-11" name="dei:LocalPhoneNumber">765-5500</ix:nonNumeric></span></p><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s Telephone Number, Including Area Code)</p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"><p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric contextRef="duration_2024-01-11_to_2024-01-11" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr> </table><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric contextRef="duration_2024-01-11_to_2024-01-11" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr> </table><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric contextRef="duration_2024-01-11_to_2024-01-11" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr> </table><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric contextRef="duration_2024-01-11_to_2024-01-11" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr> </table><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section 12(b) of the Act:</p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric contextRef="duration_2024-01-11_to_2024-01-11_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember" name="dei:Security12bTitle">Common Stock, par value 12 1/2 cents per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric contextRef="duration_2024-01-11_to_2024-01-11_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember" name="dei:TradingSymbol">IFF</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric contextRef="duration_2024-01-11_to_2024-01-11_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric contextRef="duration_2024-01-11_to_2024-01-11_us-gaap-StatementClassOfStockAxis_iff-A1.750SeniorNotesDue2024Member" name="dei:Security12bTitle">1.75% Senior Notes due 2024</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric contextRef="duration_2024-01-11_to_2024-01-11_us-gaap-StatementClassOfStockAxis_iff-A1.750SeniorNotesDue2024Member" name="dei:TradingSymbol">IFF 24</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric contextRef="duration_2024-01-11_to_2024-01-11_us-gaap-StatementClassOfStockAxis_iff-A1.750SeniorNotesDue2024Member" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric contextRef="duration_2024-01-11_to_2024-01-11_us-gaap-StatementClassOfStockAxis_iff-A1.800SeniorNotesDue2026Member" name="dei:Security12bTitle">1.800% Senior Notes due 2026</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric contextRef="duration_2024-01-11_to_2024-01-11_us-gaap-StatementClassOfStockAxis_iff-A1.800SeniorNotesDue2026Member" name="dei:TradingSymbol">IFF 26</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric contextRef="duration_2024-01-11_to_2024-01-11_us-gaap-StatementClassOfStockAxis_iff-A1.800SeniorNotesDue2026Member" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></td></tr> </table><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company <ix:nonNumeric contextRef="duration_2024-01-11_to_2024-01-11" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p><p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p><p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div><p style='page-break-before:always'></p> <hr style="color:#999999;height:3px;width:100%" /> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top"><span style="font-weight:bold">Item&#160;5.02</span></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</p></td></tr></table><p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">(b)</p><p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">International Flavors&#160;&amp; Fragrances Inc. (&#8220;IFF&#8221; or the &#8220;Company&#8221;) announced on January&#160;11, 2024 that Mr.&#160;Franklin&#160;K. Clyburn, Jr. who is currently Chief Executive Officer (&#8220;CEO&#8221;) of the Company and a director of the Company&#8217;s Board of Directors (the &#8220;Board&#8221;), will cease to serve as CEO and a director of the Board, effective February&#160;6, 2024. Mr.&#160;Clyburn is expected to remain employed with the Company in a transitional role until March&#160;31, 2024, and subsequently is expected to provide advisory services in a consulting role until December&#160;31, 2024. Mr.&#160;Clyburn&#8217;s departure is a qualifying event for purposes of IFF&#8217;s Amended and Restated Executive Severance Policy (the &#8220;Executive Severance Policy&#8221;). Per the terms and conditions of the Executive Severance Policy, Mr.&#160;Clyburn is entitled to termination benefits consisting of (i)&#160;a cash separation payment equal to two times the sum of (A)&#160;Mr.&#160;Clyburn&#8217;s annual base salary plus (B)&#160;Mr.&#160;Clyburn&#8217;s target annual bonus opportunity for fiscal year 2024, prorated based upon the number of active days of employment (ii) 24 months of benefits continuation and <span style="white-space:nowrap">(iii)&#160;pro-rata</span> vesting of his outstanding restricted share unit, stock appreciation rights and performance share unit awards (with performance share units remaining subject to achievement of actual performance at the end of the applicable performance period). In addition, per the terms and conditions of Mr.&#160;Clyburn&#8217;s letter agreement with the Company, dated January&#160;18, 2022, the <span style="white-space:nowrap">sign-on</span> equity awards granted to Mr.&#160;Clyburn on March&#160;1, 2022 will continue to vest in full (with performance share units remaining subject to achievement of actual performance at the end of the applicable performance period). As consideration for his consulting services from April&#160;1, 2024 through December&#160;31, 2024, Mr.&#160;Clyburn will receive a total consulting fee of $1,000,000, paid in equal monthly installments. In connection with the foregoing, the Company entered into a separation and transition agreement with Mr.&#160;Clyburn on January&#160;11, 2024 (the &#8220;Clyburn Agreement&#8221;), a copy of which is attached hereto as Exhibit 10.1 and the terms and conditions of which are incorporated by reference herein.</p><p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">(c)</p><p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On January&#160;11, 2024, the Company announced that, effective February&#160;6, 2024, J. Erik Fyrwald has been appointed CEO of the Company and has been appointed to serve as a director of the Board. He will also be named to the Board&#8217;s Innovation Committee and Transaction Committee. Mr.&#160;Fyrwald, 64, previously served as the CEO and executive director of the board of directors of the Syngenta Group, a leading global agriculture company, from June 2016 to December 2023, and he served as the chairman of the Syngenta Foundation from 2018 to December 2023. Mr.&#160;Fyrwald is currently a member of the board of directors of the Syngenta Group and Eli Lilly and Company.</p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&#160;Fyrwald does not have any family relationships with any director or executive officer of the Company, and there are no arrangements or understandings with any persons pursuant to which Mr.&#160;Fyrwald has been appointed to his position. In addition, there have been no transactions directly or indirectly involving Mr.&#160;Fyrwald that would be required to be disclosed pursuant to Item 404(a) of Regulation <span style="white-space:nowrap">S-K</span> under the Securities Exchange Act of 1934, as amended.</p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with Mr.&#160;Fyrwald&#8217;s appointment as CEO, the Company entered into a letter agreement with Mr.&#160;Fyrwald on January&#160;11, 2024 (the &#8220;Agreement&#8221;), a copy of which is attached hereto as Exhibit 10.2 and the terms and conditions of which are incorporated by reference herein.</p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the Agreement, Mr.&#160;Fyrwald will be entitled to the following compensation: (1)&#160;annual base salary of $1,000,000; (2) a target annual bonus opportunity of 200% of Mr.&#160;Fyrwald&#8217;s annual base salary; (3)&#160;participation in the Company&#8217;s Long-Term Incentive Plan (the &#8220;LTIP&#8221;) with a target award opportunity for the annual 2024 grant cycle of $10,00,000 (60% in performance share units and 40% in restricted stock units) (the &#8220;Target LTI&#8221;); and (4)&#160;as an inducement to have Mr.&#160;Fyrwald accept the offer from the Company, <span style="white-space:nowrap">one-time</span> equity awards consisting of a target award of 68,750 performance share units and 56,250 restricted stock units (the &#8220;Inducement Awards&#8221;). It is expected that the Inducement Awards will be granted on March&#160;1, 2024 as &#8220;employment inducement awards&#8221; under the NYSE Listed Company Manual Rule 303A.08.</p></div></div><p style='page-break-before:always'></p> <hr style="color:#999999;height:3px;width:100%" /> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event Mr.&#160;Fyrwald&#8217;s employment is terminated by the Company without &#8220;cause&#8221; or by Mr.&#160;Fyrwald for &#8220;good reason&#8221;, Mr.&#160;Fyrwald will be entitled to the benefits provided in the Executive Severance Policy and to the continued vesting of the restricted stock unit portion of the Inducement Award in full on the existing vesting schedule. In addition, under the Security Agreement which is attached as Exhibit B to his Agreement and the terms and conditions of which are incorporated by reference herein, Mr.&#160;Fyrwald is subject to <span style="white-space:nowrap">non-competition</span> covenants while employed by the Company and for one year following a termination of employment, <span style="white-space:nowrap">non-solicitation</span> covenants while employed by the Company and for two years following a termination of employment, and ongoing confidentiality, cooperation and <span style="white-space:nowrap">non-disparagement</span> covenants. Mr.&#160;Fyrwald will not receive any additional compensation for his service on the Board.</p><p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top"><span style="font-weight:bold">Item&#160;9.01</span></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits.</p></td></tr></table><p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">(d) Exhibits.</p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td style="width:92%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold">Number</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">Description</span></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d712376dex101.htm">Separation and Transition Agreement between International Flavors&#160;&amp; Fragrances Inc. and Franklin K. Clyburn, Jr., effective January&#160;11, 2024 </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d712376dex102.htm">Letter Agreement between International Flavors&#160;&amp; Fragrances Inc. and J. Erik Fyrwald, effective January&#160;11, 2024 </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr></table></div></div><p style='page-break-before:always'></p> <hr style="color:#999999;height:3px;width:100%" /> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES</p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:40%;border:0;margin-left:auto">
<tr>
<td style="width:10%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:89%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">INTERNATIONAL&#160;FLAVORS&#160;&amp;&#160;FRAGRANCES&#160;INC.</p></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jennifer Johnson</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Name:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Jennifer Johnson</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Executive Vice President, General Counsel and Corporate Secretary</td></tr></table></div><p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: January&#160;11, 2024</p></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>d712376dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SEPARATION AGREEMENT </U></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>AND GENERAL RELEASE </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This
Separation Agreement and General Release (this &#147;<U>Agreement</U>&#148;), dated as of January&nbsp;11, 2024, is entered into by and between International Flavors&nbsp;&amp; Fragrances Inc. (the &#147;<U>Company</U>&#148;) and Frank Clyburn
(&#147;<U>you</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <B><U>Termination of Employment</U></B>. This Agreement sets forth the benefits you are eligible to receive
under the Company&#146;s Amended and Restated Executive Severance Policy (the &#147;<U>Severance Policy</U>&#148;) as a result of your separation from the Company, as well as other benefits being provided to you and obligations you agree to comply
with in connection with your separation, subject to your compliance with the terms and conditions of the Severance Policy and the terms and conditions set forth herein. You acknowledge and agree that (a)&nbsp;your employment with the Company or its
affiliates (the &#147;<U>Group Companies</U>&#148;) and (b)&nbsp;the offer letter between you and the Company dated January&nbsp;18, 2022 will terminate effective as of the close of business March&nbsp;31, 2024 (the &#147;<U>Separation
Date</U>&#148;). Therefore, as of the Separation Date you will cease to be employed by the Group Companies. You acknowledge and agree that, effective as February&nbsp;6, 2024 (the &#147;<U>Transition Date</U>&#148;), you will cease serving as Chief
Executive Officer and as an officer of the Company and you will be deemed to have resigned from the Board of Directors of the Company (the &#147;<U>Board</U>&#148;) and such other titles, roles and positions of the Group Companies as determined by
the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <B><U>Transition Services</U></B>. From the Transition Date through the Separation Date (such period the
&#147;<U>Transition Period</U>&#148;) you will be employed by the Company as a Senior Advisor and available on a <FONT STYLE="white-space:nowrap">full-time</FONT> basis to provide those duties and responsibilities as requested by the Board from time
to time, including ensuring a smooth integration and transition of your current responsibilities to the Company&#146;s new Chief Executive Officer and for cooperation with the Investigation (as defined in Section&nbsp;10(i)). The Board may, in its
sole discretion, place you on garden leave during the Transition Period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <B><U>Transition and Separation Payments and
Benefits</U></B>. In exchange for the releases and covenants contained in this Agreement and, with respect to the benefits described in paragraphs <FONT STYLE="white-space:nowrap">(b)-(g)</FONT> below, the Final Release (as defined in
Section&nbsp;6(b)), and subject to your compliance with all of the covenants and provisions contained herein and therein, the Company agrees to provide you with the following payments and benefits, subject to the occurrence of the First Effective
Date (as defined in Section&nbsp;18 of this Agreement) and, with respect to the benefits described in paragraphs <FONT STYLE="white-space:nowrap">(b)-(g)</FONT> below, the Second Effective Date (as defined in Section&nbsp;18 of this Agreement).
<B>For the avoidance of doubt, if the Second Effective Date does not occur within twenty-eight (28)</B><B></B><B>&nbsp;days following the Separation Date, no payments or benefits will be provided to you pursuant to paragraphs (b)</B><B><FONT
STYLE="white-space:nowrap">-(g)</FONT> below.</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <B><U>Salary, Perquisites and Medical Benefits during Transition Period</U></B>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Salary</U>. The Company will continue to pay your current rate of base salary ($1,300,000 annually) through the duration of the
Transition Period. You acknowledge and agree that during the Transition Period, you will not be eligible to earn an annual bonus in respect of the Company&#146;s 2024 fiscal year, and except as expressly contemplated in Section&nbsp;3(d) you will
not be eligible to receive any <FONT STYLE="white-space:nowrap">long-term</FONT> incentive or other equity or <FONT STYLE="white-space:nowrap">equity-based</FONT> awards (including any new long-term incentive or other equity or equity-based awards
that would have otherwise been granted in accordance with the Company&#146;s annual grant cycle for 2024). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) <U>Medical Benefits</U>.
You will be eligible for group medical, dental and life insurance coverage through the duration of the Transition Period. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <B><U>Separation Payment</U></B>. In accordance with the Severance Policy, the Company
will pay you a lump sum cash payment equal to $3,575,000, which amount is comprised of the following: two (2)&nbsp;times (i) your annual base salary as of the Separation Date and (ii)&nbsp;your target annual incentive opportunity under the
Company&#146;s Annual Incentive Plan (&#147;<U>AIP</U>&#148;) for the year in which the Separation Date occurs, prorated based on your number of active days of employment during the performance period (the &#147;<U>Separation Payment</U>&#148;). The
Separation Payment will be payable to you in a lump sum within sixty (60)&nbsp;days following the Second Effective Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <B><U>Annual
Incentive Plan Payment</U></B>. In accordance with the AIP, the Company will pay you a <FONT STYLE="white-space:nowrap">lump-sum</FONT> cash payment which represents the 2023 annual incentive award under the AIP to which you would have been entitled
to receive based on actual performance had your employment with the Company not been terminated. The AIP Payment will be payable to you in a lump sum payable on the normally scheduled payout date. Such payment shall be in full settlement of your
rights under the AIP<B>. </B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <B><U>LTIP Awards</U></B>. In accordance with the terms of the Severance Policy, each long-term
incentive award (each, an &#147;<U>LTIP Award</U>&#148;) outstanding as of your Separation Date shall be governed by the terms of the LTIP Award and the applicable award agreement (the &#147;<U>Award Agreement</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) For LTIP Cycle XXII and LTIP Cycle XXIII, you will receive an LTIP Award equal to the product of (x)&nbsp;the actual performance
achievement levels for the performance segment during which your Separation Date occurred and (y)&nbsp;a fraction, the numerator of which is the number of days during such performance segment preceding your Separation Date and the denominator of
which is the total number of days in such performance segment. The LTIP Award will be settled based on actual performance on the original vesting date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the avoidance of doubt, <U>Exhibit A</U> to this Agreement summarizes your outstanding LTIP Awards that are covered by this
Section&nbsp;3(d). Your LTIP Award will be payable on the normally scheduled payout date set forth in the Award Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)
<B><U>Continued Benefits</U></B>. For a period commencing on the first of the month immediately following your Separation Date until the earlier of (i)&nbsp;twenty-four (24)&nbsp;months following your Separation Date, (ii)&nbsp;the date you commence
eligibility for benefits under a new employer&#146;s welfare benefit plans, and (iii)&nbsp;the date you attain age&nbsp;65, subject to your continued <FONT STYLE="white-space:nowrap">co-payment</FONT> of premiums, you will be eligible for continued
participation of you and your eligible dependents in all medical, dental, vision and life insurance benefit plans of the Company, in each case, as may be in effect from time to time (collectively, the &#147;<U>Benefit Plans</U>&#148;) (for the
avoidance of doubt, Benefit Plans shall not include the Company&#146;s group accident insurance and group disability insurance), upon the same terms and conditions in effect from time to time for active employees of the Company, as determined in
good faith by the Committee as such term is defined in the Severance Policy (&#147;<U>Benefit Continuation</U>&#148;). Benefit Continuation shall be provided concurrently with any health care benefit required under the Consolidated Omnibus Budget
Reconciliation Act (&#147;<U>COBRA</U>&#148;), to the extent applicable to you. Notwithstanding the foregoing, if the Company&#146;s providing Benefit Continuation would violate the nondiscrimination rules applicable to <FONT
STYLE="white-space:nowrap">non-grandfathered</FONT> plans, or would result in the imposition of penalties under the Patient Protection and Affordable Care Act of 2010 and the related regulations and guidance promulgated thereunder (the
&#147;<U>PPACA</U>&#148;), the Committee shall have the right to amend this Section&nbsp;3(e) in a manner it determines, in its sole discretion, to comply with the PPACA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <B><U>Vacation Pay</U></B>. Within 30 days following your Separation Date, the Company will make a payment to you for your accrued and
unused 2024 vacation, if any. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <B><U>Expenses</U></B>. You will be reimbursed for your reasonable business expenses incurred on or
before your Separation Date in accordance with the Company&#146;s expense reimbursement policy as may be in effect from time to time. In addition, the Company will pay your reasonable professional fees, upon presentation of one or more invoices
therefor, incurred to negotiate an prepare this Agreement and related agreements hereunder, in amount not to exceed $20,000. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <B><U>Equity Plan Benefits</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) In accordance with the terms and conditions of the Company&#146;s 2021 Stock Award and Incentive Plan (the &#147;<U>2021 SAIP</U>&#148;),
with respect to any of your purchased restricted stock, restricted stock units, <FONT STYLE="white-space:nowrap">stock-settled</FONT> appreciation rights, options or other equity awards in respect of the common stock of the Company, as listed in the
schedule set forth in <U>Exhibit</U><U></U><U>&nbsp;A</U> (collectively, &#147;<U>Equity Awards</U>&#148;) remaining outstanding as of your Separation Date: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(A)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A <FONT STYLE="white-space:nowrap">pro-rata</FONT> portion of any Equity Award carrying a right to exercise
that was not previously exercisable and vested shall remain outstanding and become vested on the applicable vesting date as though your employment with the Company had not been terminated, as set forth in the applicable award agreement;
<U>provided</U>, <U>however</U>, any Equity Award subject to Code Section&nbsp;409A shall become exercisable and vested in a manner compliant with Code Section&nbsp;409A. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(B)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A <FONT STYLE="white-space:nowrap">pro-rata</FONT> portion of any outstanding and unvested Equity Award shall
remain outstanding and become vested on the vesting date or dates as though your employment with the Company had not been terminated, as set forth in the applicable award agreement. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(C)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The <FONT STYLE="white-space:nowrap">pro-rata</FONT> portion of the Equity Award shall be determined by
multiplying the number of unvested Equity Awards by a fraction, (x)&nbsp;the numerator of which is the number of days from the applicable grant date to the Separation Date and (y)&nbsp;the denominator of which is the number of days from the
applicable grant date to the applicable vesting date. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) With respect to your restricted stock units, deferred stock
units, stock-settled appreciation rights and performance-based restricted stock units granted on March&nbsp;1, 2022 (collectively, the &#147;<U><FONT STYLE="white-space:nowrap">Sign-on</FONT> Award</U>&#148;), the unvested portion of the <FONT
STYLE="white-space:nowrap">Sign-on</FONT> Award as of your Separation Date shall remain outstanding and subject to continued vesting as though your employment with the Company had not been terminated. The performance-based restricted stock unit
portion of the Sign on Award shall vest subject to actual performance. The portion of the <FONT STYLE="white-space:nowrap">Sign-on</FONT> Award carrying a right to settlement will be settled within thirty (30)&nbsp;days following the applicable
vesting date, but in any but in any event no later than March 15<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> of the year following the year in which vesting occurs. The tranche of the stock-settled appreciation rights portion of the <FONT
STYLE="white-space:nowrap">Sign-on</FONT> Award (the &#147;<U>SSARs</U>&#148;) that has vested as of the Separation Date will remain outstanding and exercisable until one year following the Separation Date. SSARs that become vested following the
Separation Date will remain outstanding and exercisable until the first anniversary of the date on which they vest. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)
<B><U>401(k)</U></B>. If you are a participant in the Company&#146;s 401(k) plan, you will receive written correspondence from Fidelity at the beginning of the month following your Separation Date. In the meantime, if you need to contact Fidelity,
they can be reached at netbenefits.com or 800 835 5095. Your contributions, and the Company&#146;s matching contributions on your behalf, to your 401(k) account will cease as of your Separation Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) <B><U>Deferred Compensation Plan</U></B>. Any amounts you have deferred under the Company&#146;s Amended and Restated Deferred
Compensation Plan (the &#147;<U>DCP</U>&#148;) will be paid out in accordance with the terms of the DCP. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) <B><U>Termination of All
Other Benefits</U></B>. Except as specifically set out in this Section&nbsp;3, all other benefits shall cease as of the Separation Date, including Accidental Death and Dismemberment Insurance, Vision Coverage and Short and Long-Term Disability
Insurance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <B><U>Payments and Satisfaction</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) You acknowledge and agree that, other than as specifically set forth in this Agreement, you are not due any compensation or benefits under
any benefit plan, program or policy of the Company or any of its affiliates, including without limitation compensation for unpaid salary, unpaid bonus, commissions, disability benefits, severance, or accrued or unused vacation time or vacation pay,
that you have received all leave (paid or unpaid), commissions and notice period to which you are entitled, you have not worked any uncompensated time (regular or overtime), have no known workplace injuries or occupational diseases, and that no
other remuneration or benefits are due to you arising from or relating to your employment with the Company or the termination of your employment. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Payments under this Agreement will be made by the Company using such method of payment
as it may determine in its discretion, including without limitation, by direct deposit to your bank account. Unless you advise the Company&#146;s Payroll Department in writing of any changes to your banking information, any payments by direct
deposit shall be into such bank account as is currently on file with the Payroll Department. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <B><U>Consulting Services</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) From the April&nbsp;1, 2024 through December&nbsp;31, 2024 (such period, the &#147;<U>Consulting Period</U>&#148;), the Company hereby
agrees, and you hereby agree, to provide consulting services to the Company as set forth in this Section&nbsp;5. During the Consulting Period, you will be available to provide services as requested by the Company in the areas of your expertise and
to cooperate with the Investigation (as defined in Section&nbsp;10(i)) (the &#147;<U>Consulting Services</U>&#148;). You agree to perform the Services in good faith and to the best of your ability. It is expected that your Consulting Services will
be less than twenty percent (20%) of the services you provided as a full-time employee of the Company. For clarity, during the Consulting Period, you may engage in any other business, profession or occupation for compensation or otherwise that does
not (i)&nbsp;materially interfere with your duties under this letter or (ii)&nbsp;result in a breach of any of the restrictive covenants contained in Section&nbsp;10 of this Agreement or to which you are otherwise subject. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) In consideration for your performance of the Consulting Services, the Company will pay to you a total consulting fee of $1,000,000, which
will be paid to you in equal monthly installments, in arrears, during the Consulting Period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) During the Consulting Period, you shall
be an independent contractor of the Company, and this letter shall not be construed to create any association, partnership, joint venture, employee or agency relationship between you and the Company for any purpose. Except to the extent specifically
authorized in advance by the Company in writing, during the Consulting Period, you (a)&nbsp;shall have no authority (and shall not hold yourself out as having authority) to represent, bind or act on behalf or in the name of the Company, and
(b)&nbsp;shall not make any agreements or representations on behalf of the Company. For the avoidance of doubt, during the Consulting Period, you will not be eligible to participate in any vacation, group medical or life insurance, disability,
profit sharing or retirement benefits or any other fringe benefits or benefit plans offered by the Company to employees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <B><U>General
Release and Waiver of All Claims</U></B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) In consideration of the agreements set forth herein, which you acknowledge to be good and
valuable consideration for this release, you on your own behalf and on behalf of your successors, heirs, beneficiaries, agents, assigns, and representatives (collectively, the &#147;<U>Releasors</U>&#148;) hereby forever voluntarily, knowingly, and
willingly waive and release, to the fullest extent permitted by law, the Company and its parents, subsidiaries, predecessors, affiliated entities, successors and assigns, together with each of those entities&#146; respective former, current and
future managers, owners, officers, directors, partners, shareholders, employees, agents, representatives, fiduciaries, insurers and reinsurers, administrators, and employee benefit plans and programs, both individually and in their business
capacities (collectively, the &#147;<U>Releasees</U>&#148;), from any and all claims, complaints, liabilities, grievances, causes of action, demands or rights, known, unknown or hereafter discovered, of any nature whatsoever which any Releasor now
has or in the future may have against any Releasee, of whatever kind or nature arising out of any actions, inactions, conduct, decisions, behavior, or events occurring on or prior to the date you sign this Agreement, whether known, unknown or
hereafter discovered, including, without limitation, any and all claims of negligence, </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
breach of contract, wrongful refusal to hire, wrongful discharge, invasion of privacy, attorneys&#146; fees, violation of federal, state and local laws that prohibit discrimination on the basis
of race, color, national origin, religion, sex, age and disability, arising directly or indirectly from or related to, your employment or the termination thereof, harassment, whistle blowing or violation of federal, state and local laws that
prohibit retaliation in employment. By way of example only and without limitation, this waiver and release is applicable to any claims under The National Labor Relations Act; Title VII of the Civil Rights Act of 1964; Sections 1981 through 1988 of
Title 42 of the United States Code; The Employee Retirement Income Security Act of 1974, as amended (except for any vested benefits under any tax qualified benefit plan); The Immigration Reform and Control Act; The Americans with Disabilities Act;
The Rehabilitation Act; The Age Discrimination in Employment Act (&#147;<U>ADEA</U>&#148;); The Older Workers Benefit Protection Act (&#147;<U>OWBPA</U>&#148;); The Lilly Ledbetter Fair Pay Act; The Occupational Safety and Health Act; The Worker
Adjustment and Retraining Notification Act; The Genetic Information and Discrimination Act; The Fair Credit Reporting Act; The Family and Medical Leave Act; The Equal Pay Act; The Uniformed Services Employment and Reemployment Rights Act; The
Employee Polygraph Protection Act; The employee (whistleblower) civil protection provisions of the Corporate and Criminal Fraud Accountability Act (Sarbanes-Oxley Act); the Securities and Exchange Act; the Dodd-Frank Act; and any other federal,
state, local or other law, rule, regulation, constitution, code, guideline or ordinance; any public policy, contract (oral or written, express or implied), tort, or common law; or any claims for vacation, sick or personal leave pay, short term or
long term disability benefits, or payment pursuant to any practice, policy, handbook or manual; or any basis for recovering costs, fees, or other expenses, including but not limited to attorneys&#146; fees and/or costs. Further, you agree to waive
all applicable State law claims, including but not limited to those set forth in <U>Exhibit</U><U></U><U>&nbsp;B</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) As of the
Separation Date, you will be required to execute and deliver to the Company a Final General Release in the form of <U>Exhibit C</U> (the &#147;<U>Final Release</U>&#148;), and the Second Effective Date must have occurred within twenty-eight
(28)&nbsp;days following the Separation Date, in order to obtain those benefits set forth in Sections 3(b)-(g) above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <B><U>Exclusions
from &#147;Release and Waiver&#148; of Claims</U></B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) You understand and agree that nothing in this Agreement limits your right to
bring an action to enforce the terms of this Agreement or to bring a proceeding pursuant to the OWBPA to challenge the validity of the release of claims pursuant to the ADEA consistent with the Equal Employment Opportunity Commission Enforcement
Guidance On <FONT STYLE="white-space:nowrap">Non-Waivable</FONT> Employee Rights Under <FONT STYLE="white-space:nowrap">EEOC-Enforced</FONT> Statutes dated April&nbsp;11, 1997. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) You understand that the Release and Waiver contained in Section&nbsp;6 above does not include a waiver of any claims, which cannot be
waived by law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) You understand and agree that nothing in this Agreement, or any prior agreement you may have with any Releasee,
prohibits or restricts you from lawfully communicating truthful information, or cooperating with, or otherwise assisting in an investigation by any governmental agency or <FONT STYLE="white-space:nowrap">self-regulatory</FONT> organization regarding
a possible violation of any federal law or responding to any inquiry from any such organization, including an inquiry about the existence of this Agreement or its underlying facts, without first notifying Releasees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) You warrant that you have not filed any suit, charge, complaint, grievance or proceeding against any Releasee in any court of the United
States or any state or local governmental subdivision thereof, or with any administrative agency or arbitration panel, concerning any claim, demand, issue or cause of action covered by this Agreement (excluding any whistleblowing or similar claim,
complaint or action with any federal, state or local governmental agency). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) You are not waiving your right to the payments, benefits,
and protections to be paid or provided pursuant to this Agreement after the date hereof. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) You are not waiving your right to indemnification under the Company&#146;s Articles of
Incorporation or any applicable policy of insurance, bylaws, agreement of indemnity or any other applicable agreement or vehicle, in connection with your service as an employee, officer or member of the board of directors of the Company or any of
its affiliates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <B><U>No Admission of Wrongdoing</U></B>. By entering into this Agreement, you agree that the Releasees do not admit,
but in fact deny, any wrongdoing or violation of any law. The existence and execution of this Agreement shall not be considered, and shall not be admissible in any proceeding, as an admission by the Releasees of any liability, error, violation or
omission. You affirm that all of the Company decisions regarding your pay and benefits through the date you sign this Agreement were not discriminatory based on age, disability, race, color, sex, religion, national origin or any other classification
protected by law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <B><U>No Other Proceedings or Claims</U></B>. You affirm that you are not a party to, and have not filed, any claim,
complaint, or action against any Releasee in any forum (excluding any whistleblowing or similar claim, complaint or action with any federal, state or local governmental agency). You affirm that you have not complained of, and are not aware of, any
fraudulent activity or any acts which would form the basis of a claim of fraudulent or illegal activity by the Company or any of its officers, and that you have disclosed to the Company any information you have concerning any conduct involving the
Company, any of its affiliates or any of their respective employees that you have any reason to believe may be unlawful. You further acknowledge and agree that as of the date you sign this Agreement: (i)&nbsp;you have advised the Company of all
facts of which you are aware that you believe may constitute a violation of the Company&#146;s Code of Business Conduct and Ethics (the &#147;<U>Conduct Code</U>&#148;), compliance policies, and/or legal obligations, including under the U.S. federal
securities laws; (ii)&nbsp;the Company has resolved those issues to your satisfaction; (iii)&nbsp;you are not aware of any current violations of the Conduct Code, compliance policies, or legal obligations, including those under the U.S. federal
securities laws; and (iv)&nbsp;you have not suffered any adverse action as a result of your conduct in this regard. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <B><U>Restrictive
Covenants</U></B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <B><U>Security Agreement</U></B>. You acknowledge that, at the time you became employed, you signed a Security
Agreement, a copy of which is attached hereto as <U>Exhibit D</U> and fully incorporated into this Agreement by reference. You represent that you have fully abided by and will continue to be bound by the terms and conditions of the Security
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <B><U>Exiting Employee Acknowledgment/Certification</U></B>. You acknowledge that you have continuing obligations under
the Exiting Employee Acknowledgment/Certification. A copy of the Exiting Employee Acknowledgment/Certification is attached as <U>Exhibit E</U> and is incorporated into and considered a part of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <B><U>Non</U></B><B><U><FONT STYLE="white-space:nowrap">-Disparagement</FONT></U></B>. Subject to your rights contained in Section&nbsp;7,
you agree not to directly or indirectly take any actions or make any statements that criticize, ridicule, disparage or are otherwise derogatory to the Company or any of the Releasees (as defined in Section&nbsp;6) or any of their respective products
or services, financial status or businesses, or that damage or is intended to damage the Company or any of the Releasees in any of their respective business relationships, or encourage the making of such statements or the taking of such actions by
someone else. The Company agrees to instruct its directors and senior executive officers not to directly or indirectly take any actions or make any statements that criticize, ridicule, disparage or are otherwise derogatory of you or that damage or
are intended to damage you in any of your business relationships. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <B><U>Confidential and Proprietary Information</U></B>. You
acknowledge and agree that you are bound by the confidentiality provisions set forth in your Equity Documents (as defined below), your Security Agreement and Section&nbsp;9 of the Severance Policy, as in effect on the Separation Date. For the
avoidance of doubt, the following confidentiality provisions apply: </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) You agree to refrain from directly or indirectly disclosing any Confidential Information
to any person or using, selling or otherwise transferring any Confidential Information for your own benefit or the benefit of any third party. &#147;<U>Confidential Information</U>&#148; refers to confidential, proprietary or commercially sensitive
information relating to the Company or its affiliates or their employees, board members, customers, vendors, or other business partners and their businesses, operations, or affairs, including, without limitation, information relating to finances,
insurance, business strategy and plans, claims, products, formulations, protocols, processes, designs, formulae, ideas, <FONT STYLE="white-space:nowrap">know-how,</FONT> test methods, evaluation techniques, patents, trade secrets, scientific or
technical data, regardless of the form in which it is maintained or provided, orally or in writing, whether prepared by the Company, a third party or you, together with all analyses, compilations, notes and other documents. Notwithstanding the
foregoing, nothing in this Agreement shall be construed to prohibit or limit you from reporting suspected violations of law to any governmental authority, or from making other disclosures protected by law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) You further agree that the terms of this Agreement shall be considered Confidential Information and that prior to this Agreement becoming
publicly available, you shall not disclose any information contained in this Agreement to any person, other than, (i)&nbsp;your immediate family members, (ii)&nbsp;as required by law, (iii)&nbsp;with the express written authority of the Company,
(iv)&nbsp;for the purposes of obtaining confidential accounting, financial or legal advice, or (v)&nbsp;for the purposes of enforcing this Agreement. If you do tell your lawyer, financial advisor or immediate family members about this Agreement or
its contents, you must immediately tell each such individual that he or she must keep such information confidential as well. Notwithstanding the foregoing, you shall be permitted to disclose the covenants contained in this Section&nbsp;10 to any
prospective employers. Except as provided in the preceding sentence, upon inquiry regarding the subject matter contained in this Agreement or regarding the Agreement, you shall either not respond or state only that the matter has been resolved. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) You further acknowledge and agree that in accordance with the Defend Trade Secrets Act of 2016, you will not be held criminally or
civilly liable under any federal or state trade secret law for disclosure of a trade secret that: (A)&nbsp;is made (1)&nbsp;in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney, and
(2)&nbsp;solely for the purpose of reporting or investigating a suspected violation of law; or (B)&nbsp;is made in a complaint or other document that is filed under seal in a lawsuit or other proceeding. You acknowledge and agree that if you file a
lawsuit for retaliation by the Company for reporting a suspected violation of law, you may disclose the Company&#146;s trade secrets to your attorney and use the trade secret information in the court proceeding if you (a)&nbsp;file any document
containing the trade secret under seal, and (b)&nbsp;do not disclose the trade secret, except pursuant to court order. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)
<B><U>Non</U></B><B><U><FONT STYLE="white-space:nowrap">-Solicitation</FONT></U></B>. You acknowledge and agree that you are bound by the <FONT STYLE="white-space:nowrap">non-solicitation</FONT> provisions set forth in your Equity Documents, your
Security Agreement and Section&nbsp;9 of the Severance Policy, as in effect on the Separation Date and such provisions are incorporated into and considered a part of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <B><U>Non</U></B><B><U><FONT STYLE="white-space:nowrap">-Compete</FONT></U></B>. You acknowledge and agree that you are bound by the
restrictions on competition set forth in your Equity Documents, your Security Agreement, Section&nbsp;9 of the Severance Policy, as in effect on the Separation Date (collectively, the &#147;<U><FONT STYLE="white-space:nowrap">Non-Compete</FONT>
Restrictions</U>&#148;) and such <FONT STYLE="white-space:nowrap">Non-Compete</FONT> Restrictions are incorporated into and considered a part of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <B><U>Return of Company Property</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) As of your Separation Date, and before the Company is obligated to make any payments to you or provide you with any benefit pursuant to
this Agreement, and except as otherwise mutually agreed between you and the Company in writing relating to the performance of the Consulting Services during the Consulting Period pursuant to Section&nbsp;5 of this Agreement, you shall return to the
Company all property of the Company and its affiliates, customers and vendors in your possession or control, including without limitation, all materials, work product or documents containing or pertaining to Confidential Information, and including
without limitation, any Company </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
car, all computers (including laptops), cell phones, keys, PDAs, Blackberries, iPhones, Androids, iPads, credit cards, printers, facsimile machines, televisions, card access to any Company
building, parking passes, office keys, customer lists, reports, files, <FONT STYLE="white-space:nowrap">e-mails,</FONT> work papers, memoranda, notes, formulae, tapes, programs, records and software, computer access codes or disks, internal or
external hard drives, thumb drives, instructional manuals, and other similar materials or documents which you had access to, used, received or prepared, helped prepare or supervised the preparation of in connection with your employment with the
Company (collectively, &#147;<U>Company Property</U>&#148;). Notwithstanding the foregoing, the Company agrees that you shall be permitted to retain your Company mobile phone, laptop, iPad and related peripherals, provided that it is cleansed and
purged by the Company&#146;s IT Department of all Confidential Information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) You hereby represent, warrant, and agree that you
(i)&nbsp;have not retained and will not retain any copies, duplicates, reproductions or excerpts of and have not used, recreated or reproduced (other than in the proper performance of your duties to the Company) and will not use, recreate or
reproduce any Company Property, (ii)&nbsp;have not transmitted or stored and will not transmit or store any Company Property to or on any personal electronic messaging systems or devices, and (iii)&nbsp;have not transmitted and will not transmit any
Company Property to any unauthorized person or store the same on any unauthorized person&#146;s electronic messaging system or device. Personal electronic messaging systems and devices include, but are not limited to, personal computers, laptops, <FONT
STYLE="white-space:nowrap">e-mail</FONT> accounts, internal or external hard drives, thumb drives, cell phones, smartphones or other wireless devices, iPads, iPhones, Blackberrys, facsimile machines, instant messaging systems, or copy machines. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <B><U>Intellectual Property / Work Product</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) For the purposes of this clause, &#147;<U>Intellectual Property</U>&#148; includes all Confidential Information, inventions whether
patentable or not, patents, trademarks, formulae, service marks, designs, design rights, copyrights, utility models, applications for registration of any of the foregoing and the rights to apply for them in any part of the work, drawings, computer
programs, trade secrets, processes, ideas, <FONT STYLE="white-space:nowrap">know-how</FONT> and rights of a like nature arising or subsisting in the work, whether registered or unregistered. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) You agree that all of your work product, including all Intellectual Property, whether created solely or jointly with others, and
including any moral rights therein, given, disclosed, created, developed or prepared in connection with your employment with the Company, shall be the sole and exclusive property of the Company. In the event that any such Intellectual Property or
other work product does not vest by operation of law as the sole and exclusive property of the Company, you hereby irrevocably assign, transfer and convey to the Company, exclusively and perpetually, all right, title and interest which you may have
or acquire in and to such Intellectual Property or other work product throughout the world. The Company and its affiliates or their designees shall have the exclusive right to make full and complete use of, and make changes to, all Intellectual
Property or other work product without restrictions or liabilities of any kind, and you shall not have the right to use any such materials, other than within the legitimate scope and purpose of your employment with the Company. You affirm that you
have disclosed to the Company the creation or existence of any Intellectual Property or other work product and agree to take whatever additional lawful action may be necessary, and to sign whatever documents the Company may require, in order to
secure and vest in the Company or its designee all right, title and interest in and to any Intellectual Property or other work product and any industrial or Intellectual Property rights therein (including full cooperation in support of any Company
applications for patents and copyright or trademark registrations). To the extent additional nominal consideration is required pursuant to applicable law, you agree that such nominal consideration shall be sufficient for the assignments described
above. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <B><U>Cooperation</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) You acknowledge and agree that you are bound by the cooperation provisions set forth in your Equity Documents and Section&nbsp;9 of the
Severance Policy, as in effect on the Separation Date. You agree to make yourself available to testify on behalf of the Company in any action, suit, or proceeding, whether civil, criminal, administrative, or investigative, and to provide necessary
information and meet and consult with members of management or other representatives of, or counsel to, the Company as reasonably requested. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) Without limiting the foregoing, you acknowledge that the Company and the Group Companies have been involved in various proceedings
launched in March 2023 by certain competition and enforcement authorities in the United States, United Kingdom, Switzerland and before the EU Commission (together, the &#147;Authorities&#148;) and the Company and the Group Companies may be involved
in other procedures conducted by other competition or enforcement authorities (the &#147;Other Competent Authorities&#148;) in other jurisdictions for similar facts (together, the &#147;Investigation&#148;). You agree, as from the date of this
Agreement, to fully and promptly cooperate in good faith with the Company, the Group Companies and their legal counsel in any matter concerning the Investigation. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">You agree and undertake to provide all documents in your possession and all information in your knowledge, in
compliance with applicable laws, upon request from the Company, the Group Companies, their legal counsel, or the Authorities or any Other Competent Authority, and undertake to cooperate fully, at the request of the Company or any Group Company, in
the investigation. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">You agree to attend any meetings or interviews upon request from the legal counsel of the Company or the Group
Companies or the Authorities or any Other Competent Authority, anywhere within that Authority&#146;s jurisdiction, and to provide full answers to all questions concerning your duties within the Company or the Group Companies (the &#147;Duties&#148;)
or, more generally, your business activities within the Group Companies and the business activities operated by it, in a frank and honest manner, in compliance with applicable laws. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">You also undertake to cooperate with the Company and any Group Company in connection with any claim or court
action brought against the Company or any Group Company in whole or in part for any alleged violation of the antitrust laws (&#147;Derivative Actions&#148;), including, but not limited to, providing testimony at trial or deposition, in compliance
with applicable laws. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">You shall not cooperate, including serving as a consultant or expert, with any claimant acting against the
Company or any Group Company, except as authorized or requested by the Company or any Group Company, as the case may be, or as may be required by applicable law. In the event such cooperation is requested, you shall immediately inform the Company or
Group Company, as the case may be. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the event you receive a cooperation request or have any other communication with one of the Authorities, or
any Other Competent Authority, in connection with the Investigation, you shall, to the extent permitted by applicable law, immediately inform the Company or Group Companies. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This cooperation undertaking will end upon definitive expiration of the current or future proceedings related
to the Investigation undertaken by the Authorities or any Other Competent Authority, or any Derivative Actions. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Furthermore, to the maximum extent permitted by the <FONT STYLE="white-space:nowrap">by-laws</FONT> of the
Company and applicable law, the Company undertakes to advance and indemnify your reasonable legal fees and related costs pertaining to the Investigation or Derivative Actions in any jurisdiction, as well as reasonable and properly documented and
invoiced expenses for travel, meals and/or overnight stays required for the purposes of the Investigation, and this Agreement shall constitute the undertaking required pursuant to the <FONT STYLE="white-space:nowrap">by-laws</FONT> of the Company.
</P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">8.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Each party to this Agreement may immediately terminate this Section&nbsp;10(i)(ii), without prior notice, in
the event of material breach by the other party of its or his undertakings hereunder (a &#147;Breach&#148;). If either party commits a Breach, prior to termination of this Section&nbsp;10(i)(ii), where there is a reasonable possibility of a Breach
being cured, the Breach shall be notified to the defaulting party. The defaulting party shall have seven (7)&nbsp;calendar days after the date of the notification (the &#147;Cure Date&#148;) to cure the Breach. If the Breach is not cured,
termination of this Section&nbsp;10(i)(ii) will take effect as of the Cure Date. If there is no reasonable possibility of a Breach being cured, the termination of this Section&nbsp;10(i)(ii) will be notified to the defaulting party and will take
effect as of the date of the notification. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) <B><U>Compliance with Company Policy</U></B>. You represent that, during
your employment with the Company, you have not engaged in willful misconduct or violation of a Company policy that is materially detrimental to the Company or in any action or inaction that would constitute grounds for being terminated for Cause, as
such term is defined in the Severance Policy. Furthermore, you hereby acknowledge and agree that following your Separation Date you shall continue to be subject to, and comply with, the Company&#146;s Insider Trading Policy (including, without
limitation, the Window Period Policy for the Purchase and Sale of Company Securities by Certain Employees and Directors) and U.S. securities laws applicable to trading on material <FONT STYLE="white-space:nowrap">non-public</FONT> information, as
well as the Company&#146;s Policy for the Recovery of Erroneously Awarded Compensation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) <B><U>Execution of Documentation</U></B>. You
agree to execute any other documentation reasonably requested by the Company from time to time, and to deliver the same to the Company within such time as may be reasonably specified by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) <B><U>No Conflict</U></B>. You represent that, during your employment with the Company, you have not directly or indirectly, acting alone
or with others, engaged in any activity or work that conflicts or competes with the Company&#146;s business, including, without limitation, becoming employed by, rendering services for, engaging in business with, serving as an agent or consultant
to, or becoming a partner, member, principal, stockholder or other owner of, (i)&nbsp;any service that competes with those products or services offered by the Company, or (ii)&nbsp;any customer or vender of the Company that you have a direct working
relationship with, provided that you were permitted to hold one percent or less interest in the equity or debt securities of any publicly traded company during your employment with the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) <B><U>Resignation upon Termination</U></B>. This Agreement represents your resignation as Chief Executive Officer, as an officer of the
Company and from all board and board committee memberships, effective as of the Transition Date. You agree to execute and return to the Company, within two (2)&nbsp;business days following the Transition Date, a letter in the form attached as
<U>Exhibit F</U>, which separately confirms your resignation from such positions. You hereby agree to cooperate with the Company in executing any corporate documentation reasonably requested by the Company from time to time, and to deliver the same
to the Company within such time as may be reasonably specified by the Company, to effectuate any such resignation; provided that such documentation does not impair any of your rights pursuant to this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <B><U>Breach, Equitable Relief and Forfeiture</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) You and the Company hereby agree that the period and geographical areas of restriction imposed upon you by the provisions of
Section&nbsp;10 of this Agreement are fair and reasonable and are reasonably required for the protection of the Company. You acknowledge and agree that a breach by you of Section&nbsp;10 of this Agreement shall be deemed a material breach of this
Agreement and that remedies at law will be inadequate to protect the Company and its affiliates </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
in the event of such breach. Without prejudice to any other rights and remedies otherwise available to the Company, you agree to the granting of injunctive relief in the Company&#146;s favor in
connection with any such breach or violation without proof of irreparable harm plus, if the Company prevails, its legal fees and costs to enforce these provisions. You expressly waive any security or bond that might otherwise be required in
connection with such relief. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) You further acknowledge and agree that the Company&#146;s obligation to make any payments to you or
provide you with any benefit or right pursuant to this Agreement is subject to your compliance with your obligations under Section&nbsp;10, and that in the event of a breach by you of this Agreement, (i)&nbsp;you shall be obligated to immediately
repay to the Company all amounts and benefits theretofore paid to or received by you pursuant to this Agreement; and/or (ii)&nbsp;you shall forfeit any further payments or benefits under this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) You further acknowledge and agree that you are subject to the terms of Section&nbsp;9(b)(i) and (b)(ii) of the Severance Policy, pursuant
to which you may be required to repay to the Company some or all of the payments made to you under this Agreement. You hereby agree to repay to the Company any such amounts as are determined by the Company under Section&nbsp;9(b)(i) and 9(b)(ii) of
the Severance Policy in the event such event occurs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) You further acknowledge that under the terms of the 2021 SAIP and your other
applicable award agreements (collectively, the &#147;<U>Equity Documents</U>&#148;), if you fail to comply with your obligations under Section&nbsp;32(b) of the 2021 SAIP, including the <FONT STYLE="white-space:nowrap">non-competition,</FONT> <FONT
STYLE="white-space:nowrap">non-solicitation,</FONT> confidentiality and cooperation obligations thereunder, or if a restatement or misstatement of the Company&#146;s financial statements is required, some or all of your AIP, LTIP Award, Equity
Choice Program and other <FONT STYLE="white-space:nowrap">stock-based</FONT> or cash awards may be subject to forfeiture or repayment in accordance with the terms of the respective award agreements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. <B><U>Taxes</U></B>. You agree that you are responsible for all applicable taxes and contributions relating to the payments and benefits
under this Agreement and that all payments and benefits under this Agreement shall be subject to applicable taxation deductions and withholdings. You understand and agree that the Company is providing you with no representations regarding tax
obligations or consequences that may arise from this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. <B><U>Assignment; Severability</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) You expressly agree that this Agreement shall be assignable by the Company to a successor to any of the businesses of the Company and you
hereby expressly consent to such assignment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) In the event that any one or more of the provisions of this Agreement shall be or become
invalid, illegal or unenforceable in any respect, including the restrictions in Section&nbsp;9 but excluding the general release language, the validity, legality and enforceability of the remaining provisions contained herein shall not be affected
thereby. If the general release language is found to be illegal or unenforceable, you agree to execute a binding replacement release. In the event that one or more terms or provisions of this Agreement are deemed invalid or unenforceable by the laws
of New York or any other state or jurisdiction in which it is to be enforced, by reason of being vague or unreasonable as to duration or geographic scope of activities restricted, or for any other reason, the provision in question shall be
immediately amended or reformed to the extent necessary to make it valid and enforceable by the court of such jurisdiction charged with interpreting and/or enforcing such provision. You agree and acknowledge that the provision in question, as so
amended or reformed, shall be valid and enforceable as though the invalid or unenforceable portion had never been included herein. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. <B><U>Entire Agreement and Waiver</U></B>. Effective as of the Separation Date, this
Agreement (including all attachments and schedules hereto, including the Final Release) constitutes the entire agreement between you and the Company with respect to the termination of your employment, and supersedes all other correspondence, offers,
proposals, promises, agreements or arrangements relating to the subject matter contained herein (including, without limitation, your offer letter dated January&nbsp;18, 2022 between you and the Company and the Severance Policy). The failure of any
party to at any time enforce any of the provisions of this Agreement shall not be deemed or construed to be a waiver of any such provisions, nor in any way affect the validity of this Agreement or any provision hereof or the right of either of the
parties to thereafter enforce each and every provision of this Agreement. You acknowledge that you have not relied on any representation, promises, or agreements of any kind made in connection with the decision to sign this Agreement, except for
those set forth in this Agreement, including the Exhibit(s) that are incorporated herein in their entirety. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. <B><U>No
Modification</U></B>. This Agreement may not be changed unless the changes are in writing and signed by you and an authorized representative of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16. <B><U>Notice</U></B>. All notices or other communications required or permitted to be given hereunder shall be in writing and shall be
delivered by hand or sent by facsimile or sent, postage prepaid, by registered, certified or express mail or overnight courier service and shall be deemed given when so delivered by hand or facsimile, or if mailed, three days after mailing (one
business day in the case of express mail or overnight courier service) to the parties at the following address: (a)&nbsp;for the Company: Executive Vice President, General Counsel, 521 West 57th Street, New York, NY 10019-2960; and (b)&nbsp;for you,
the most recent address on file for you. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17. <B><U>Governing Law</U></B>. The terms of this Agreement shall for all purposes be enforced,
governed by, and construed in accordance with the laws of the State of New York except to the extent governed by the Employee Retirement Income Security Act of 1974 (ERISA), as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18. <B><U>Acknowledgments</U></B>. By signing this Agreement, you acknowledge that: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) You have carefully read and understand this Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The Company has advised you in writing to consult with an attorney of your choosing before signing this Agreement and you have, in fact,
retained and been represented by legal counsel of your own choosing in connection with, and before signing, this Agreement, and that the time afforded to you to consider the terms of this Agreement has provided you with a full and fair opportunity
to thoroughly discuss all aspects of your rights and this Agreement with an attorney; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) You acknowledge that you have had a reasonable
period of <FONT STYLE="white-space:nowrap">twenty-one</FONT> (21)&nbsp;calendar days (the &#147;<U>Review Period</U>&#148;) to review and consider this Agreement before signing it. You understand that you may use as much of the Review Period as you
wish before signing this Agreement. If you sign this Agreement prior to the expiration of the Review Period, you are acknowledging that you have voluntarily and knowingly waived the remainder of the Review Period with respect to such claims, and
that the decision to accept a shortened period of time was not induced by the Company or any released party; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) You understand the
consequences of entering into this Agreement, including with respect to the restraints in Section&nbsp;10 and the release and waiver in Section&nbsp;6, that this Agreement is <B>LEGALLY BINDING </B>and by signing it you give up certain rights; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) You understand that, following your execution of the Agreement, you will have a period of seven (7)&nbsp;calendar days to revoke this
Agreement by delivering written notification addressed to the Company&#146;s Executive Vice President and General Counsel, 521&nbsp;West 57th Street, New York, NY <FONT STYLE="white-space:nowrap">10019-2960,</FONT> no later than the close of
business on the seventh (7th) calendar day after you sign it (except that if the seventh (7th) calendar day after you sign the Agreement falls on a Saturday, Sunday or holiday observed by the Company, you shall have until the conclusion of the
immediately next business day) (the &#147;<U>First Revocation Period</U>&#148;). For purposes of this Agreement, the &#147;<U>First Effective Date</U>&#148; as used herein shall mean the first (1st) calendar day after the First Revocation Period
expires without you revoking the Agreement. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) You understand that, following your execution of the Final Release, you will have a
period of (7)&nbsp;calendar days to revoke the Final Release by delivering written notification addressed to the Company&#146;s Executive Vice President and General Counsel, 521&nbsp;West 57th Street, New York, NY
<FONT STYLE="white-space:nowrap">10019-2960,</FONT> no later than the close of business on the seventh (7th) calendar day after you sign it (except that if the seventh (7th) calendar day after you sign the Final Release falls on a Saturday, Sunday
or holiday observed by the Company, you shall have until the conclusion of the immediately next business day) (the &#147;<U>Second Revocation Period</U>&#148;). For purposes of this Agreement, the &#147;<U>Second Effective Date</U>&#148; as used
herein shall mean the first (1st) calendar day after the Second Revocation Period expires without you revoking the Final Release. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) As
set forth in Section&nbsp;6 herein, you KNOWINGLY AND VOLUNTARILY RELEASE the Releasees from any and all claims you may have, known or unknown, as of the date you sign this Agreement, in exchange for the benefits you have obtained in the Agreement,
and that these benefits are in addition to any benefit you would have otherwise received if you did not sign this Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) If you
refuse to sign this Agreement within the Review Period or revoke this Agreement during the Revocation Period, this Agreement will not be effective and enforceable and you will not receive any of the payments or benefits set forth in Section&nbsp;3,
other than those you have a right to receive by law, if any; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) You have voluntarily chosen to enter into this Agreement and have
not been forced or pressured in any way to sign it by any person or party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">19. <B><U>Counterparts</U></B>. This Agreement may be executed
in counterparts (including by facsimile), each of which shall be deemed an original and all of which together shall constitute one and the same instrument. You or the Company may execute this Agreement by executing any counterpart. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>[Signature Page Follows] </I></B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, you and
the&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Company hereto knowingly and voluntarily executed this Agreement as of the date first written above. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">FRANK CLYBURN</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">INTERNATIONAL FLAVORS&nbsp;&amp; FRAGRANCES INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Frank Clyburn</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jennifer Johnson</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Jennifer Johnson</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:6pt ;">EVP&nbsp;&amp; General Counsel</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">January&nbsp;11, 2024</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">January&nbsp;11, 2024</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Date</P></TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT A </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SUMMARY OF OUTSTANDING EQUITY AWARDS </U></B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT B </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>STATE LAWS </U></B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT C </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>FINAL GENERAL RELEASE </U></B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT D </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>IFF SECURITY AGREEMENT </U></B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT E </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXITING EMPLOYEE CERTIFICATION/ACKNOWLEDGMENT FORM </U></B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT F </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>FORM OF RESIGNATION LETTER </U></B></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>d712376dex102.htm
<DESCRIPTION>EX-10.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">January&nbsp;11, 2024 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Personal&nbsp;&amp; Confidential
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J. Erik Fyrwald <I> </I></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>At the address on file with
the Company</I> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Erik, </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I am very pleased to confirm our
offer of employment for the position of Chief Executive Officer at International Flavors&nbsp;&amp; Fragrances Inc. (&#147;<U>IFF</U>&#148; or the &#147;<U>Company</U>&#148;) in accordance with the terms of this letter agreement
(&#147;<U>Agreement</U>&#148;). You will report to the Board of Directors of IFF (the &#147;<U>Board</U>&#148;) and work at our New York, NY location. On the Commencement Date, you will be appointed a member of the Board and thereafter nominated
annually to serve as a director during your period of employment with the Company. Additionally, you may engage in charitable and civic activities, and serve on one <FONT STYLE="white-space:nowrap">for-profit</FONT> company board of directors,
provided that such activities do not interfere with your duties with or responsibilities to the Company. In addition to your service as a Director at IFF, you will be permitted to serve as a Director on one other Board. You will resign from all
other director positions as soon as practicable, but in no event later than the end of 2024. As a trusted and critical leader, I look forward to partnering with you to transform our industry and achieve our objectives. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other terms of your employment with us are as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><U>Effective Date</U></B><B>.</B> Employment in your new role will commence on February&nbsp;6, 2024
(&#147;<U>Commencement Date</U>&#148;). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><U>Base Salary</U></B><B>.</B> Your annual base salary will be $1,000,000 (&#147;<U>Base
Salary</U>&#148;). Future adjustments of your salary will be determined by the Board based on your performance. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><U>Vacation</U></B><B>.</B> You will be eligible for four weeks of paid vacation annually (plus
holiday break), of which up to five unused vacation days can be carried over and will accrue future vacation in accordance with the applicable vacation policy as in effect from time to time. Upon a termination of your employment for any reason, you
will receive payment for any accrued unused vacation in accordance with the terms and conditions of the Company&#146;s applicable vacation policy as in effect from time to time. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><U>Annual Bonus</U></B><B>.</B> You will be eligible to receive an annual cash bonus award (the
&#147;<U>Annual Bonus</U>&#148;) for each fiscal year ending during the period you are employed by the Company. The Annual Bonus shall be governed by the terms and conditions of the Company&#146;s Annual Incentive Plan (the &#147;<U>AIP</U>&#148;).
You shall be eligible to earn a target Annual Bonus equal to 200% of your Base Salary for the relevant fiscal year (the &#147;<U>Target Bonus</U>&#148;), if the Company achieves the target performance goals established by the Board for such fiscal
year. Your Annual Bonus could be higher or lower than the Target Bonus depending on the Company&#146;s performance and/or your individual performance, with the maximum bonus potential equal to 200% of target. Your 2024 target Annual Bonus will not
be <FONT STYLE="white-space:nowrap">pro-rated.</FONT> The Annual Bonus for each fiscal year shall be payable at the time annual bonuses are paid to other eligible participants of the Company in accordance with the terms of the AIP. The specific
terms of your Annual Bonus awards will be governed by the AIP award agreements relating to each award and you will be required to accept your Annual Bonus and agree to the terms and conditions thereof by signing an AIP award agreement each year. The
Annual Bonus (including your Target Bonus) is a discretionary, <FONT STYLE="white-space:nowrap">non-contractual</FONT> benefit which, subject to the requirements of a Good Reason termination under the Executive Severance Plan, may be amended or
withdrawn at any time. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><U>Long-Term Incentive Plan</U></B><B>.</B> You will be eligible to receive an annual long-term
incentive award (&#147;<U>LTIP Award</U>&#148;), which shall be determined and payable in accordance with the Company&#146;s Long-Term Incentive Plan (the &#147;<U>LTIP</U>&#148;) under the Company&#146;s 2021 Stock Award and Incentive Plan (the
&#147;<U>2021 SAIP</U>&#148;), as such plan may be amended from time to time. Your total target award under the LTIP for the 2024 plan year will be $10,000,000, 60% of which will be performance share units and 40% of which will be restricted stock
units. Any awards under the LTIP for future years shall be at the sole discretion of the Board. The specific terms of your awards under the LTIP will be governed by the award agreements relating to each award, and you will be required to accept and
agree to the terms and conditions thereof by signing the award agreements each year. The awards under the LTIP are discretionary, <FONT STYLE="white-space:nowrap">non-contractual</FONT> benefits, which may be amended or withdrawn at any time.
</P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><U><FONT STYLE="white-space:nowrap">One-Time</FONT> Inducement Equity Grants</U></B><B>.</B> You will
receive the following <FONT STYLE="white-space:nowrap">one-time</FONT> inducement awards with the vesting schedule shown in <U>Exhibit A</U>: a target award of 68,750 performance share units and 56,250 restricted stock units (collectively, the
&#147;<U>Inducement Awards</U>&#148;). Upon a termination without Cause, with Good Reason or due to Disability (each as defined in the Executive Severance Policy, with &#147;Good Reason&#148; as modified below) or death, the restricted stock unit
portion of the Inducement Award will continue to vest in full on its existing vesting schedule, subject to continued compliance with the restrictive covenants in the Security Agreement. Each Inducement Award shall be governed by the terms and
conditions of the Company&#146;s 2021 SAIP, as such plan may be amended from time to time, and an award agreement which will further describe the terms and conditions of such Inducement Award in addition to the terms above, and which you will be
required to accept and acknowledge for such Inducement Award to become effective. The Inducement Awards are anticipated to be granted on the first business day of the month following your Commencement Date. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>7.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><U>Share Retention</U></B><B>.</B> You are subject to the applicable ownership level under the
Company&#146;s Share Retention Policy, as amended from time to time. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>8.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><U>Perquisites</U></B><B>.</B> You will be eligible for an annual perquisite allowance of $20,000 to
be used in any combination across the following categories: personal financial counseling and income tax preparation, health and fitness and legal and estate planning, subject to the terms and conditions of the applicable Company policy in effect
from time to time. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>9.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><U>Car Benefit</U></B><B>.</B> During your employment with the Company, you will be entitled to
receive an annual allowance of $25,000 to be used towards the purchase or lease of a vehicle of your choice. Notwithstanding anything herein to the contrary, the car benefit is subject to, and contingent upon, your continued employment with the
Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>10.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><U>Employee Benefits; Expenses</U></B><B>.</B> You will be eligible to participate in the employee
benefit plans and programs maintained by IFF from time to time for other similarly situated employees at your location and job level, in each case, in accordance with their terms and conditions then in effect. You will be entitled to reimbursement
of your unreimbursed business expenses incurred during your employment with the Company in accordance with the terms and conditions of the applicable Company policy. The Company will pay your reasonable professional fees, upon presentation of one or
more invoices therefor, incurred to negotiate and prepare this Agreement and related agreements hereunder, in amount not to exceed $20,000. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>11.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><U>Relocation</U></B><B>.</B> The Company will pay or reimburse you for the relocation expenses
described in its U.S. Domestic Relocation Policy for homeowners Level&nbsp;8 to Executive, dated October&nbsp;29, 2021, and made a part hereof, with temporary housing modified to be up to 90 days, in connection with your move. Enclosed is a
description of, and conditions and limitations relating to, the relocation benefits applicable to you. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>12.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><U>Compliance with Company Policies</U></B><B>.</B> You hereby agree to comply with all Company
policies, procedures, rules and regulations applicable to you, including without limitation, the Company&#146;s Code of Business Conduct and Ethics, the Drug and Alcohol Policy, the Confidential and Proprietary Information Policy, the Insider
Trading Policy (including Window Period Policy for the Purchase and Sale of Company Securities by Certain Employees and Directors), the Policy for the Recovery of Erroneously Awarded Compensation and the Conflict of Interest Policy (collectively,
the &#147;<U>Policies</U>&#148;), in each case, as they may be amended from time to time in the Company&#146;s sole discretion. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>13.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><U>Security Agreement</U></B><B>.</B> This offer of employment is contingent upon your execution of
the enclosed Security Agreement concerning the protection of Company confidential information, intellectual property rights, and other restrictive covenants in the form attached as <U>Exhibit B</U>. You acknowledge that you have executed and
delivered the Security Agreement to the Company with this Agreement. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>14.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><U>At Will Employment</U></B><B>.</B> You agree and acknowledge that this Agreement does not
guarantee or promise any particular period of future employment to you. Your employment with the Company is on an &#147;at will&#148; basis and may be terminated by the Company or by you at any time for any reason upon written notice, without any
obligation owing by the Company, except as may be provided in the Company&#146;s Executive Severance Policy, as amended, at the Tier I: Chief Executive Officer level, as in effect at the time of termination and otherwise stated herein. You
acknowledge a copy of the Executive Severance Policy, as amended, has been provided to you. Notwithstanding any provision of the Executive Severance Policy to the contrary: (a)&nbsp;clause (ii) of the definition of &#147;Good Reason&#148; in the
Executive Severance Plan shall also include a material diminution in reporting responsibilities and removal from or failure to renominate you to the Board at any time; provided, that such removal does not include (i)&nbsp;removal as result of a
failed shareholder vote or (ii)&nbsp;removal from the Board for Cause, (b)&nbsp;upon termination without Cause or for Good Reason, you will be entitled to receipt of (i)&nbsp;any unpaid annual bonus earned based on actual performance for the year
preceding the year in which your termination occurs, and (ii)&nbsp;any vested performance share units earned based on actual performance, pursuant to the Inducement Award or otherwise, if your termination occurs following the completion of the
performance segment in which such performance share units vested but prior to the settlement of such performance share units, (c)&nbsp;any arbitration under Section&nbsp;13(f) shall be conducted under the American Arbitration Association&#146;s
rules governing employment disputes, and (d)&nbsp;any amendment or termination of the Executive Severance Policy materially adverse to you shall be disregarded to the extent becoming effective prior to the third anniversary of the Commencement Date.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>15.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><U>Data Protection</U></B><B><U></U></B><B><U>&nbsp;&amp; Privacy</U></B><B>.</B> You acknowledge
that the Company, directly or through its affiliates, collects and processes data (including personal sensitive data and information retained in email) relating to you. You hereby consent to such collection and processing and, by signing this
Agreement, acknowledge that you authorize such activities. To ensure regulatory compliance and for the protection of its employees, customers, vendors and business, the Company reserves the right to monitor, intercept, review and access telephone
logs, internet usage, voicemail, email and other communication facilities provided by the Company which you may use during your employment with IFF. The Company will use this right of access reasonably, but it is important that you are aware that
all communications and activities on our equipment or premises cannot be presumed to be private. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>16.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><U>Entire Agreement</U></B><B>.</B> This Agreement, including the Security Agreement and any
schedules, attachments or addenda, constitutes the entire agreement between you and the Company with respect to your employment and supersedes all prior correspondence, offers, proposals, promises, offer letters, agreements or arrangements relating
to the subject matter contained herein. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>17.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><U>Modification</U></B><B>.</B> The terms of this Agreement may not be changed unless the changes are
approved in writing by an authorized representative of the Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>18.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><U>Governing Law</U></B><B>.</B> The terms of this Agreement shall be governed by, and construed in
accordance with, the laws of the State of New York. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>19.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><U>Withholding</U></B><B>.</B> Payments of Base Salary and other compensation and benefits will be
subject to all applicable taxes and other withholdings, and the Company may withhold all such taxes and other withholdings from any payments made to you as required by law. In addition, if at any time any amounts are owed and payable by you to the
Company, it is agreed that, to the extent permissible, the Company may deduct such sums from time to time owed from any payment due to you from the Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>20.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B><U>409A Compliance</U></B>. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>(a)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>General.</B> It is the intention of both the Company and you that the benefits and rights to which you could
be entitled pursuant to this Agreement comply with Section&nbsp;409A of the Internal Revenue Code, the Treasury Regulations and other guidance promulgated or issued thereunder (&#147;<U>Section</U><U></U><U>&nbsp;409A</U>&#148;), to the extent that
the requirements of Section&nbsp;409A are applicable thereto, and the provisions of this Agreement shall be construed in a manner consistent with that intention. If you or the Company believes, at any time, that any such benefit or right that is
subject to Section&nbsp;409A does not so comply, you or the Company shall promptly advise the other and shall negotiate reasonably and in good faith to amend the terms of such benefits and rights such that they comply with Section&nbsp;409A (with
the most limited possible economic effect on you and on the Company). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>(b)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Distributions on Account of Separation from Service.</B> If and to the extent required to comply with
Section&nbsp;409A, no payment or benefit required to be paid under this Agreement on account of termination of your employment shall be made unless and until you incur a &#147;separation from service&#148; within the meaning of Section&nbsp;409A.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>(c)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>No Acceleration of Payments.</B> Neither the Company nor you, individually or in combination, may accelerate
any payment or benefit that is subject to Section&nbsp;409A, except in compliance with Section&nbsp;409A and the provisions of this Agreement, and no amount that is subject to Section&nbsp;409A shall be paid prior to the earliest date on which it
may be paid without violating Section&nbsp;409A. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>(d)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Treatment of Each Installment as a Separate Payment and Timing of Payments.</B> For purposes of applying the
provisions of Section&nbsp;409A to this Agreement, each separately identified amount to which you are entitled under this Agreement shall be treated as a separate payment. In addition, to the extent permissible under Section&nbsp;409A, any series of
installment payments under this Agreement shall be treated as a right to a series of separate payments. Whenever a payment under this Agreement specifies a payment period with reference to a number of days, the actual date of payment within the
specified period shall be within the sole discretion of the Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>(e)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Taxable Reimbursements and <FONT STYLE="white-space:nowrap">In-Kind</FONT> Benefits.</B> Any reimbursements
by the Company to you of any eligible expenses under this Agreement that are not excludable from your income for federal income tax purposes (the &#147;<U>Taxable Reimbursements</U>&#148;) shall be made by no later than the earlier of the date on
which they would be paid under the Company&#146;s normal policies and the last day of the taxable year of the employee (you) following the year in which the expense was incurred. The amount of any Taxable Reimbursements, and the value of any <FONT
STYLE="white-space:nowrap">in-kind</FONT> benefits to be provided to you, during any taxable year of the employee (you) shall not affect the expenses eligible for reimbursement, or <FONT STYLE="white-space:nowrap">in-kind</FONT> benefits to be
provided, in any other taxable year of the Employee (you). The right to Taxable Reimbursement, or <FONT STYLE="white-space:nowrap">in-kind</FONT> benefits, shall not be subject to liquidation or exchange for another benefit. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>(f)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Postponement of Payment if a Specified Employee.</B> To the extent any amounts payable upon your separation
from service are nonqualified deferred compensation under Section&nbsp;409A taking into account all applicable exceptions, and if you are at such time a &#147;specified employee&#148; thereunder, then to the extent required under Section&nbsp;409A
payment of such amounts shall be postponed until six (6)&nbsp;months following the date of your separation from service (or until any earlier date of your death), upon which date all such postponed amounts shall be paid to you in a lump sum, and any
remaining payments due under the Agreement shall be paid as otherwise provided herein or other applicable plan or agreement. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Erik, I
hope you share in my excitement on the path IFF is taking to become the global leader in high-value ingredients and solutions for Food&nbsp;&amp; Beverage, Home&nbsp;&amp; Personal Care and Health&nbsp;&amp; Wellness. I look forward to working with
you to achieve our goals in 2024 and beyond. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Please sign the enclosed copy of this letter and return it, together with the accompanying Security
Agreement to me. Please feel free to call me if you have any questions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page Follows</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Your sincerely,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Roger W. Ferguson, Jr.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Roger W. Ferguson, Jr.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Agreed and Accepted by:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ J. Erik Fyrwald</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">J. Erik Fyrwald</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT A </U></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="37%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="36%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>Award</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Number&nbsp;of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Shares</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="8" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Terms</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Performance Share Units</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:10pt">68,750 (target)</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B><I>Dividend-Adjusted Ending</I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B><I>Stock Price $</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B><I>&nbsp;</I></B><BR> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman"><B><I></I></B></P></TD>
<TD VALIGN="bottom" ALIGN="center"><B><I>PSU&nbsp;Funding</I></B><BR> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B><I>% of Target</I></B></P></TD>
<TD NOWRAP VALIGN="bottom"><B><I>&nbsp;</I></B><BR> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:8pt; font-family:Times New Roman"><B><I>&nbsp;</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B><I>&nbsp;</I></B></TD>
<TD VALIGN="bottom" ALIGN="center"><B><I>#&nbsp;of&nbsp;PSUs&nbsp;Earned</I></B></TD>
<TD NOWRAP VALIGN="bottom"><B><I>&nbsp;</I></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" BGCOLOR="#cceeff">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP BGCOLOR="#cceeff">&lt;$106.48</TD>
<TD VALIGN="bottom" BGCOLOR="#cceeff">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#cceeff">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#cceeff" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#cceeff">%&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#cceeff">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#cceeff">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#cceeff" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#cceeff">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$106.48</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34,375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" BGCOLOR="#cceeff">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP BGCOLOR="#cceeff">$113.91</TD>
<TD VALIGN="bottom" BGCOLOR="#cceeff">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#cceeff">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#cceeff" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#cceeff">%&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#cceeff">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#cceeff">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#cceeff" ALIGN="right">68,750</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#cceeff">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>$121.67</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">150</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">103,125</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" BGCOLOR="#cceeff">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP BGCOLOR="#cceeff">$138.25</TD>
<TD VALIGN="bottom" BGCOLOR="#cceeff">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#cceeff">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#cceeff" ALIGN="right">200</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#cceeff">%&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#cceeff">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#cceeff">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#cceeff" ALIGN="right">137,500</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#cceeff">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>&#8805; $156.25</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">250</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">171,875</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="57%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Minimum funding of 50% of target if (1)&nbsp;the Company&#146;s <FONT
STYLE="white-space:nowrap">3-year</FONT> Relative TSR is at or above the 67<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> percentile of S&amp;P 500 companies and (2)&nbsp;the Company&#146;s <FONT STYLE="white-space:nowrap">3-year</FONT>
Absolute TSR is positive.</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Dividend Adjusted Ending Stock Price is calculated as the sum of (x)&nbsp;the average closing
price for the 20 consecutive trading days preceding March&nbsp;1, 2027 (the &#147;<U>Measurement Date</U>&#148;) plus (y)&nbsp;the aggregate value of any dividends paid or declared on IFF shares between March&nbsp;1, 2024 (the &#147;<U>Grant
Date</U>&#148;) and the Measurement Date (assuming such dividends are reinvested in IFF shares).</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Relative TSR is calculated by measuring the change in the market price of a share of IFF common
stock plus dividends paid or declared (assuming such dividends are reinvested in IFF shares) for the Company and the S&amp;P&nbsp;500 companies (as determined on the Grant Date) between the Grant Date and the Measurement Date. The market price for
purposes of calculating the TSR of IFF shares and the S&amp;P&nbsp;500 companies is determined based on the average closing price per share of the applicable company over the period of 20 consecutive trading days preceding the Grant Date and the
Measurement Date.</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Absolute TSR is calculated by measuring the change in the market price of a share of IFF common
stock plus dividends paid or declared (assuming such dividends are reinvested in IFF shares) between the Grant Date and the Measurement Date. The market price for purposes of calculating the TSR of IFF shares is determined based on the average
closing price per share of Company common stock over the period of 20 consecutive trading days preceding the Grant Date and the Measurement Date.</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Upon termination without cause, with good reason, or due to disability (each as defined in the
Executive Severance Policy, as modified by this Agreement) or death, each a &#147;<U>Qualifying Termination</U>&#148;), vesting will accelerate on a <FONT STYLE="white-space:nowrap">pro-rated</FONT> basis (number of full months worked divided by 36
months) based on actual performance through the date of termination.</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;In the event of a change in control as defined in the Executive Severance Policy, the performance
share units will be converted into a number of time-based restricted stock units based on actual performance as of the date of the change in control. As restricted stock units, in the event of a Qualifying Termination following such change in
Control, the restricted stock units will vest in full as of the date of termination and will be settled as soon as reasonably practicable thereafter in accordance with the terms and conditions of the
LTIP.</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Restricted Stock Units</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">56,250</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">&#149;&#8195;&#8202;3-year</FONT> cliff vesting.</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;In the event of a Qualifying
Termination, the restricted stock units will continue to vest in full on the existing vesting schedule.</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;In the event of a Qualifying Termination following a change in control, as defined in the
Executive Severance Policy, vesting will accelerate in full as of the date of termination and will be settled as soon as reasonably practicable thereafter in accordance with the terms and conditions of the LTIP.</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT B </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONFIDENTIAL </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IFF
SECURITY AGREEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In consideration of an offer of employment made to me by International Flavors&nbsp;&amp; Fragrances Inc. (the
&#147;<U>Company</U>&#148;), I hereby agree as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Confidentiality. </B>I agree that during my employment with the Company or any of its Affiliates as defined
below (individually and collectively, &#147;<U>IFF</U>&#148;) and thereafter, I will not, directly or indirectly (a)&nbsp;disclose any Confidential Information (as defined below) to any person (other than, only with respect to the period that I am
employed by IFF, to an employee or outside advisor of IFF who requires such information to perform his or her duties for IFF) or (b)&nbsp;use any Confidential Information for my own benefit or the benefit of any third party. For the purposes of this
Agreement: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<U>Confidential Information</U>&#148; shall mean confidential, proprietary, or commercially sensitive
information relating to IFF or its employees, board members, customers, vendors, or other business partners and their businesses, operations, or affairs, including, without limitation, information relating to products, formulations, protocols,
processes, designs, formulae, ideas, <FONT STYLE="white-space:nowrap">know-how,</FONT> test methods, evaluation techniques, patents, trade secrets, scientific or technical data, regardless of the form in which it is maintained or provided, orally or
in writing, whether prepared by IFF, a third party or me, together with all analyses, compilations, notes and other documents. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<U>Affiliate</U>&#148; shall mean any person or entity which controls, is controlled by or is under
common control with the Company, now or in the future. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">For the avoidance of doubt, I understand that nothing in this
Agreement shall be deemed to prohibit or restrict me from lawfully communicating truthful information to, or cooperating with, or otherwise assisting in an investigation by any governmental agency or self-regulatory organization regarding a possible
violation of law, or responding to any inquiry from any such organization, without first notifying the Company, and my doing so shall not constitute a breach of this Agreement. I understand that if I communicate any Confidential Information to a
governmental agency or self-regulatory agency pursuant to this Section, I shall notify the agency of the confidentiality of such Confidential Information and ask the agency to also protect the confidentiality of such Confidential Information. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">I also understand that in accordance with the Defend Trade Secrets Act of 2016, I will not be held criminally or civilly liable under any
federal or state trade secret law for disclosure of a trade secret that: (a)&nbsp;is made (1)&nbsp;in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney, and (2)&nbsp;solely for the purpose
of reporting or investigating a suspected violation of law; or (b)&nbsp;is made in a complaint or other document that is filed under seal in a lawsuit or other proceeding. I understand that if I file a lawsuit for retaliation by the Company for
reporting a suspected violation of law, I may disclose the Company&#146;s trade secrets to my attorney and use the trade secret information in the court proceeding if I (a)&nbsp;file any document containing the trade secret under seal, and
(b)&nbsp;do not disclose the trade secret, except pursuant to court order. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Use of <FONT STYLE="white-space:nowrap">Non-IFF</FONT> Systems.</B> I agree that I will not send
Confidential Information to, or store or receive Confidential Information on, any <FONT STYLE="white-space:nowrap">non-IFF</FONT> system (other than through access2.iff.com, if applicable), including personal or third-party <FONT
STYLE="white-space:nowrap">e-mail</FONT> accounts, devices, computers, telephones, smartphones or other wireless devices, iPads, Blackberrys, facsimiles, instant messaging systems, cloud storage or copy machines. The foregoing restriction does not
apply to printing documents on a personal or third-party printer for legitimate business purposes, while using a Company device or access2.iff.com, provided that such documents are appropriately stored at an IFF facility or shredded after such use.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Assignment of Intellectual Property</B><B>.</B> I agree that all of my work product, including all
Intellectual Property (as defined below), whether created solely or jointly with others, and including any moral rights therein, given, disclosed, created, developed or prepared in connection with my employment with IFF, shall be the sole and
exclusive property of IFF. In the event that any such Intellectual Property or other work product does not vest by operation of law as the sole and exclusive property of IFF, I hereby irrevocably assign, transfer and convey to IFF, exclusively and
perpetually, all right, title and interest which I may have or acquire in and to such Intellectual Property or other work product throughout the world. IFF shall have the exclusive right to make full and complete use of, and make changes to, all
Intellectual Property or other work product without restrictions or liabilities of any kind, and I shall not have the right to use any such materials, other than within the legitimate scope and purpose of my employment with IFF. I agree to take
whatever additional lawful action may be necessary, and to sign whatever documents IFF may require, in order to secure and vest in IFF or its designee all right, title and interest in and to any Intellectual Property or other work product and any
industrial or Intellectual Property rights therein (including full cooperation in support of any IFF applications for patents and copyright or trademark registrations). To the extent additional nominal consideration is required pursuant to
applicable law, I agree such nominal consideration shall be sufficient for the assignments described above. &#147;<U>Intellectual Property</U>&#148; includes all Confidential Information, inventions whether patentable or not, patents, trademarks,
formulae, service marks, designs, design rights, copyrights, utility models, applications for registration of any of the foregoing and the rights to apply for them in any part of the work, drawings, computer programs, trade secrets, formulae,
processes, ideas, <FONT STYLE="white-space:nowrap">know-how</FONT> and rights of a like nature arising or subsisting in the work, whether registered or unregistered. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Restrictive Covenants.</B> I acknowledge and agree that I will have access to Confidential Information and a
key role in the management of the business and will establish and develop important relationships with the customers and vendors of IFF throughout the world, all of which constitute valuable goodwill of, and could be used to compete unfairly with
IFF. I agree it would cause grave harm to IFF if I breached any of the restrictive covenants in this Section&nbsp;4, and therefore IFF has legitimate business interests in protecting its goodwill and Confidential Information, which justify the
following restrictive covenants: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><FONT STYLE="white-space:nowrap">Non-Solicitation.</FONT></B> I agree that during my employment and for a
period of twenty-four (24)&nbsp;months following the separation of my employment with IFF, I shall not directly or indirectly, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">i.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">solicit, induce, divert, employ, retain or interfere with or attempt to influence the relationship of IFF with,
any person or entity that is or was, during the last twelve (12)&nbsp;months of my employment with IFF, (A)&nbsp;an employee of IFF or (B)&nbsp;a person engaged to provide services to IFF; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">ii.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">interfere with or attempt to influence the relationship of IFF with any customer, supplier or other person with
whom IFF does business. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>No Conflict.</B> I agree that during my employment with IFF I shall not directly or indirectly, acting alone
or with others, engage in any activity or work that conflicts or competes with IFF&#146;s business, including, without limitation, becoming employed by, rendering services for, engaging in business with, serving as an agent or consultant to, or
becoming a partner, member, principal, stockholder or other owner of, (i)&nbsp;any individual or entity that develops, manufactures, sells, and/or distributes a product or service that competes with those products or services offered by IFF, or
(ii)&nbsp;any customer or vendor of IFF that I have had a direct working relationship with, provided that I shall be permitted to hold one percent or less interest in the equity or debt securities of any publicly traded company.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><FONT STYLE="white-space:nowrap">Non-Compete.</FONT></B> I covenant and agree that so long as I am employed
by IFF and for a period of twelve (12)&nbsp;months after such employment ends for any reason, whether voluntarily or involuntarily, I will not, without the prior express written consent of the Executive Vice President of Human Resources or his or
her designee, directly or indirectly become employed by, render services for, serve as an agent or consultant to, or become a partner, member, principal, stockholder or other owner of, any Competing Business. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">A &#147;<U>Competing Business</U>&#148; as used in this Agreement, means any individual or entity that develops, manufactures, sells, and/or
distributes a product or service that competes directly or indirectly with those products or services offered by IFF during the last two (2)&nbsp;years of my employment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Return of IFF Property</B>. I agree that upon separation of my employment with IFF for any reason and/or
upon IFF&#146;s demand, I shall return to IFF all property of IFF, its customers and vendors in my possession or control including, without limitation, all materials, work product or documents containing or pertaining to IFF Confidential
Information, and including without limitation, any company car, all computers (including laptops), cell phones, keys, PDAs, Blackberries, iPhones, Androids, iPads, credit cards, printers, facsimile machines, televisions, card access to any company
building, customer lists, reports, files, <FONT STYLE="white-space:nowrap">e-mails,</FONT> work papers, memoranda, notes, formulae, tapes, programs, records and software, computer access codes or disks, instructional manuals, and other similar
materials or documents which I used, received or prepared, helped prepare or supervised the preparation of in connection with my employment with IFF. I agree not to retain any copies, duplicates, reproductions or excerpts of any of the
aforementioned materials or documents and shall not at any time use, recreate or reproduce any said materials or documents. Any exceptions must be approved in writing by the Executive Vice President of Human Resources and the applicable Executive
Committee member. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Prior Employers</B>. I acknowledge and agree that IFF has no interest in and will not accept divulgence to
it of any confidential or <FONT STYLE="white-space:nowrap">non-public</FONT> knowledge or information relating to any previous employer or other third party. Notwithstanding any other Section of this Agreement, I shall not communicate any such
knowledge or information to IFF nor use the same during the course of my employment with IFF. My employment with IFF and my compliance with the terms and conditions of this Agreement will not conflict with or result in the breach of any agreement
between me and any prior employer. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Equitable Relief</B>. I agree and acknowledge that remedies at law for a breach by me of this Agreement may
be inadequate to protect IFF and, without prejudice to any other rights and remedies otherwise available to IFF, I agree to the granting of injunctive relief in IFF&#146;s favor in connection with any such breach or violation without proof of
irreparable harm, plus attorneys&#146; fees and costs, to enforce these provisions. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">8.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Severability.</B> In the event that any one or more of the provisions of this Agreement shall be or become
invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions contained herein shall not be affected thereby. Additionally, while I consider the undertakings and restrictions in this
Agreement to be reasonable in all circumstances and the duration, extent and application of each of the undertakings and restrictions to be no greater than is necessary to protect the proprietary interests of IFF, if one or more should be held to be
wholly or partially invalid, illegal or unenforceable as an unreasonable condition or restraint of trade or for any other reason whatsoever but would have been held valid if part of the wording thereof had been deleted or the period thereof reduced
or the range of activities or area dealt with reduced in scope, I acknowledge and agree that the said undertakings and restriction shall apply with such modifications as may be necessary to make them valid and effective. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">9.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Transfer of Undertakings. </B>The covenants set forth in this Agreement shall also apply in respect of any
legal successors of the Company or IFF, including, in particular to any purchaser of the Company or IFF, should it be sold. I agree to the transfer of the rights arising from this Agreement to the legal successor. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">10.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Governing law.</B> This Agreement shall be governed by and construed in accordance with the laws of New York
without reference to principles of conflicts of laws. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">11.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Third Party Beneficiaries.</B><B> </B>I acknowledge and agree that all Affiliates of the Company&nbsp;are
intended third party beneficiaries of this Agreement (each, a &#147;<U>Third Party Beneficiary</U>&#148;) and as such, each is legally entitled to enforce its provisions in the event of a breach.&nbsp;I further acknowledge and agree that a dispute
or conflict arising under this Agreement, which in a Third Party Beneficiary&acute;s sole opinion compromises its interest, may be submitted by such Third Party Beneficiary to the courts located in the country in which the Third Party Beneficiary is
located, and in such event, notwithstanding Section&nbsp;10 above, the Agreement shall be deemed as governed by and construed in accordance with the laws of such country without reference to principles of conflicts of laws. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">12.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Compliance.</B> I acknowledge that my compliance with the foregoing obligations is a condition to my initial
and continued employment with IFF and that the obligations under this Agreement apply to me in my capacity as an employee and will apply even if my relationship with IFF were to cease, for any reason and under any circumstances. Any breach of my
obligations under this Agreement could result in disciplinary action, including termination. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">13.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Entire Agreement.</B> I acknowledge and agree that this Agreement constitutes the entire agreement between
IFF and me with respect to the subject matter of this Agreement. This Agreement replaces and supersedes any and all communications, negotiations, arrangements, oral agreements, as well as any prior writings, relating to the subject matter of this
Agreement, and prevails over any provisions of any offer letter or employment agreement between IFF and me (insofar as they relate to the subject matter of this Agreement). </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">January&nbsp;11, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="right">/s/ J. Erik Fyrwald</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">J. Erik Fyrwald</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Address</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>iff-20240111.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - Donnelley Financial Solutions, Inc. -->
<!-- CTU Version: 72.1.1 -->
<!-- Creation date: 1/11/2024 3:45:59 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:iff="http://www.iff.com/20240111"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:us-types="http://fasb.org/us-types/2023"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.iff.com/20240111"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
    <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" namespace="http://www.xbrl.org/dtr/type/2022-03-31" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" namespace="http://xbrl.sec.gov/dei/2023" />
    <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" namespace="http://fasb.org/us-gaap/2023" />
    <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" namespace="http://fasb.org/us-types/2023" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iff-20240111_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iff-20240111_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iff-20240111_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.iff.com//20240111/taxonomy/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>000001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="iff_A1.750SeniorNotesDue2024Member" name="A1.750SeniorNotesDue2024Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="iff_A1.800SeniorNotesDue2026Member" name="A1.800SeniorNotesDue2026Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>iff-20240111_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - Donnelley Financial Solutions, Inc. -->
<!-- CTU Version: 72.1.1 -->
<!-- Creation date: 1/11/2024 3:46:00 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:roleRef roleURI="http://www.iff.com//20240111/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="iff-20240111.xsd#DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.iff.com//20240111/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitiesTable" xlink:type="locator" xlink:label="dei_EntitiesTable" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInformationLineItems" xlink:type="locator" xlink:label="dei_EntityInformationLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="iff-20240111.xsd#iff_A1.750SeniorNotesDue2024Member" xlink:type="locator" xlink:label="iff_A1.750SeniorNotesDue2024Member" />
    <link:loc xlink:href="iff-20240111.xsd#iff_A1.800SeniorNotesDue2026Member" xlink:type="locator" xlink:label="iff_A1.800SeniorNotesDue2026Member" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis" xlink:type="locator" xlink:label="dei_EntityAddressesAddressTypeAxis" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain" xlink:type="locator" xlink:label="dei_AddressTypeDomain" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain" xlink:type="locator" xlink:label="dei_AddressTypeDomain_2" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherAddressMember" xlink:type="locator" xlink:label="dei_OtherAddressMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntitiesTable" order="1" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_EntitiesTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0.01" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="23" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_2" order="23.0001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="19" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="iff_A1.750SeniorNotesDue2024Member" order="20" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="iff_A1.800SeniorNotesDue2026Member" order="21" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_DocumentType" order="20.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="21.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="23.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityFileNumber" order="24.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="25.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="26.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="26.031" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="26.131" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="26.231" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_CityAreaCode" order="32.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="32.011" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_WrittenCommunications" order="34.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_SolicitingMaterial" order="35.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="36.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="37.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_Security12bTitle" order="40.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_TradingSymbol" order="41.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_SecurityExchangeName" order="42.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="43.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="46.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_AmendmentFlag" order="47.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_EntitiesTable" xlink:to="dei_EntityAddressesAddressTypeAxis" order="0.02" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain" order="48.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain_2" order="48.0011" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_AddressTypeDomain" xlink:to="dei_OtherAddressMember" order="49.001" priority="2" use="optional" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>iff-20240111_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - Donnelley Financial Solutions, Inc. -->
<!-- CTU Version: 72.1.1 -->
<!-- Creation date: 1/11/2024 3:45:59 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitiesTable" xlink:type="locator" xlink:label="dei_EntitiesTable" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitiesTable" xlink:to="dei_EntitiesTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntitiesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entities [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntitiesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entities [Table]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInformationLineItems" xlink:type="locator" xlink:label="dei_EntityInformationLineItems" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityInformationLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Information [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Information [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock, par value 12&#160;1/2&#162; per share [Member]</link:label>
    <link:loc xlink:href="iff-20240111.xsd#iff_A1.750SeniorNotesDue2024Member" xlink:type="locator" xlink:label="iff_A1.750SeniorNotesDue2024Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="iff_A1.750SeniorNotesDue2024Member" xlink:to="iff_A1.750SeniorNotesDue2024Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="iff_A1.750SeniorNotesDue2024Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">1.750% Senior Notes Due 2024 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="iff_A1.750SeniorNotesDue2024Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">1.750% Senior Notes due 2024 [Member]</link:label>
    <link:loc xlink:href="iff-20240111.xsd#iff_A1.800SeniorNotesDue2026Member" xlink:type="locator" xlink:label="iff_A1.800SeniorNotesDue2026Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="iff_A1.800SeniorNotesDue2026Member" xlink:to="iff_A1.800SeniorNotesDue2026Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="iff_A1.800SeniorNotesDue2026Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">1.800% Senior Notes Due 2026 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="iff_A1.800SeniorNotesDue2026Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">1.800% Senior Notes due 2026 [Member]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis" xlink:type="locator" xlink:label="dei_EntityAddressesAddressTypeAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_EntityAddressesAddressTypeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressesAddressTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Addresses Address Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressesAddressTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Addresses Address Type [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain" xlink:type="locator" xlink:label="dei_AddressTypeDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AddressTypeDomain" xlink:to="dei_AddressTypeDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AddressTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Address Type [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AddressTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Address Type [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherAddressMember" xlink:type="locator" xlink:label="dei_OtherAddressMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherAddressMember" xlink:to="dei_OtherAddressMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_OtherAddressMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Address [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_OtherAddressMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other Address [Member]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line 1</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address Address Line 1</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address City Or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address City Or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address State Or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address State Or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>iff-20240111_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - Donnelley Financial Solutions, Inc. -->
<!-- CTU Version: 72.1.1 -->
<!-- Creation date: 1/11/2024 3:45:59 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.iff.com//20240111/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="iff-20240111.xsd#DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.iff.com//20240111/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitiesTable" xlink:type="locator" xlink:label="dei_EntitiesTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntitiesTable" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInformationLineItems" xlink:type="locator" xlink:label="dei_EntityInformationLineItems" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntitiesTable" xlink:to="dei_EntityInformationLineItems" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntitiesTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0.01" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="iff-20240111.xsd#iff_A1.750SeniorNotesDue2024Member" xlink:type="locator" xlink:label="iff_A1.750SeniorNotesDue2024Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="iff_A1.750SeniorNotesDue2024Member" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="iff-20240111.xsd#iff_A1.800SeniorNotesDue2026Member" xlink:type="locator" xlink:label="iff_A1.800SeniorNotesDue2026Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="iff_A1.800SeniorNotesDue2026Member" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_DocumentType" order="20.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="21.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityFileNumber" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="26.031" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="26.131" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="26.231" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_CityAreaCode" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="32.011" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_WrittenCommunications" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_SolicitingMaterial" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_Security12bTitle" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_TradingSymbol" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_SecurityExchangeName" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="46.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityInformationLineItems" xlink:to="dei_AmendmentFlag" order="47.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis" xlink:type="locator" xlink:label="dei_EntityAddressesAddressTypeAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntitiesTable" xlink:to="dei_EntityAddressesAddressTypeAxis" order="0.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain" xlink:type="locator" xlink:label="dei_AddressTypeDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain" order="48.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherAddressMember" xlink:type="locator" xlink:label="dei_OtherAddressMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_AddressTypeDomain" xlink:to="dei_OtherAddressMember" order="49.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm139663501667280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jan. 11, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan. 11,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">INTERNATIONAL FLAVORS & FRAGRANCES INC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-4858<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-1432060<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address Address Line 1</a></td>
<td class="text">521 West 57th Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address City Or Town</a></td>
<td class="text">New York<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address State Or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address Postal Zip Code</a></td>
<td class="text">10019<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">765-5500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000051253<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_OtherAddressMember', window );">Other Address [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address Address Line 1</a></td>
<td class="text">200 Powder Mill Road<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address City Or Town</a></td>
<td class="text">Wilmington<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address State Or Province</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address Postal Zip Code</a></td>
<td class="text">19803<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock, par value 12&#160;1/2&#162; per share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value 12 1/2 cents per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">IFF<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=iff_A1.750SeniorNotesDue2024Member', window );">1.750% Senior Notes due 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">1.75% Senior Notes due 2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">IFF 24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=iff_A1.800SeniorNotesDue2026Member', window );">1.800% Senior Notes due 2026 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">1.800% Senior Notes due 2026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">IFF 26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_OtherAddressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_OtherAddressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=iff_A1.750SeniorNotesDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=iff_A1.750SeniorNotesDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=iff_A1.800SeniorNotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=iff_A1.800SeniorNotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>d712376d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iff="http://www.iff.com/20240111"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="iff-20240111.xsd" xlink:type="simple"/>
    <context id="duration_2024-01-11_to_2024-01-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
        </entity>
        <period>
            <startDate>2024-01-11</startDate>
            <endDate>2024-01-11</endDate>
        </period>
    </context>
    <context id="duration_2024-01-11_to_2024-01-11_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-11</startDate>
            <endDate>2024-01-11</endDate>
        </period>
    </context>
    <context id="duration_2024-01-11_to_2024-01-11_us-gaap-StatementClassOfStockAxis_iff-A1.750SeniorNotesDue2024Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">iff:A1.750SeniorNotesDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-11</startDate>
            <endDate>2024-01-11</endDate>
        </period>
    </context>
    <context id="duration_2024-01-11_to_2024-01-11_us-gaap-StatementClassOfStockAxis_iff-A1.800SeniorNotesDue2026Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">iff:A1.800SeniorNotesDue2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-11</startDate>
            <endDate>2024-01-11</endDate>
        </period>
    </context>
    <context id="duration_2024-01-11_to_2024-01-11_dei-EntityAddressesAddressTypeAxis_dei-OtherAddressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000051253</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:OtherAddressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-11</startDate>
            <endDate>2024-01-11</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2024-01-11_to_2024-01-11"
      id="Hidden_dei_EntityRegistrantName">INTERNATIONAL FLAVORS &amp; FRAGRANCES INC</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey
      contextRef="duration_2024-01-11_to_2024-01-11"
      id="Hidden_dei_EntityCentralIndexKey_duration_2024-01-11_to_2024-01-11">0000051253</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="duration_2024-01-11_to_2024-01-11"
      id="Hidden_dei_AmendmentFlag_duration_2024-01-11_to_2024-01-11">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="duration_2024-01-11_to_2024-01-11" id="Fact_1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2024-01-11_to_2024-01-11" id="Fact_0">2024-01-11</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2024-01-11_to_2024-01-11">NY</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2024-01-11_to_2024-01-11">1-4858</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2024-01-11_to_2024-01-11">13-1432060</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2024-01-11_to_2024-01-11">521 West 57th Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2024-01-11_to_2024-01-11">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2024-01-11_to_2024-01-11">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2024-01-11_to_2024-01-11">10019</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressAddressLine1
      contextRef="duration_2024-01-11_to_2024-01-11_dei-EntityAddressesAddressTypeAxis_dei-OtherAddressMember"
      id="Fact_3">200 Powder Mill Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="duration_2024-01-11_to_2024-01-11_dei-EntityAddressesAddressTypeAxis_dei-OtherAddressMember"
      id="Fact_4">Wilmington</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="duration_2024-01-11_to_2024-01-11_dei-EntityAddressesAddressTypeAxis_dei-OtherAddressMember"
      id="Fact_5">DE</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="duration_2024-01-11_to_2024-01-11_dei-EntityAddressesAddressTypeAxis_dei-OtherAddressMember"
      id="Fact_6">19803</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2024-01-11_to_2024-01-11">212</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2024-01-11_to_2024-01-11">765-5500</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2024-01-11_to_2024-01-11">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2024-01-11_to_2024-01-11">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2024-01-11_to_2024-01-11">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2024-01-11_to_2024-01-11">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2024-01-11_to_2024-01-11_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">Common Stock, par value 12 1/2 cents per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2024-01-11_to_2024-01-11_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">IFF</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2024-01-11_to_2024-01-11_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="duration_2024-01-11_to_2024-01-11_us-gaap-StatementClassOfStockAxis_iff-A1.750SeniorNotesDue2024Member">1.75% Senior Notes due 2024</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2024-01-11_to_2024-01-11_us-gaap-StatementClassOfStockAxis_iff-A1.750SeniorNotesDue2024Member">IFF 24</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2024-01-11_to_2024-01-11_us-gaap-StatementClassOfStockAxis_iff-A1.750SeniorNotesDue2024Member">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="duration_2024-01-11_to_2024-01-11_us-gaap-StatementClassOfStockAxis_iff-A1.800SeniorNotesDue2026Member">1.800% Senior Notes due 2026</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2024-01-11_to_2024-01-11_us-gaap-StatementClassOfStockAxis_iff-A1.800SeniorNotesDue2026Member">IFF 26</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2024-01-11_to_2024-01-11_us-gaap-StatementClassOfStockAxis_iff-A1.800SeniorNotesDue2026Member">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2024-01-11_to_2024-01-11">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M;%!+ 0(4 Q0    ( )""*UBT0$38[@   "L"   1              "  :\
M  !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( )""*UB97)PC$ 8  )PG
M   3              "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#
M%     @ D((K6-1ECTB2!0  7QP  !@              ("!#0@  'AL+W=O
M<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( )""*UB?H!OPL0(  .(,
M   -              "  =4-  !X;"]S='EL97,N>&UL4$L! A0#%     @
MD((K6)>*NQS     $P(   L              ( !L1   %]R96QS+RYR96QS
M4$L! A0#%     @ D((K6!PX9>H_ 0  / (   \              ( !FA$
M 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( )""*U@D'INBK0   /@!   :
M              "  083  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+
M 0(4 Q0    ( )""*UAED'F2&0$  ,\#   3              "  >L3  !;
H0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  #45      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>5</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>4</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d712376d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.iff.com//20240111/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="d712376d8k.htm">d712376d8k.htm</File>
    <File>iff-20240111.xsd</File>
    <File>iff-20240111_def.xml</File>
    <File>iff-20240111_lab.xml</File>
    <File>iff-20240111_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="32">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d712376d8k.htm": {
   "nsprefix": "iff",
   "nsuri": "http://www.iff.com/20240111",
   "dts": {
    "inline": {
     "local": [
      "d712376d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "iff-20240111.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "iff-20240111_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "iff-20240111_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "iff-20240111_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 2,
   "axisCustom": 0,
   "memberStandard": 2,
   "memberCustom": 2,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 5,
   "entityCount": 1,
   "segmentCount": 4,
   "elementCount": 33,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 32
   },
   "report": {
    "R1": {
     "role": "http://www.iff.com//20240111/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "000001 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2024-01-11_to_2024-01-11",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d712376d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2024-01-11_to_2024-01-11",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d712376d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.iff.com//20240111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.iff.com//20240111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.iff.com//20240111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://www.iff.com//20240111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses Address Type [Axis]",
        "terseLabel": "Entity Addresses Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.iff.com//20240111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.iff.com//20240111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock, par value 12\u00a01/2\u00a2 per share [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.iff.com//20240111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address City Or Town",
        "terseLabel": "Entity Address City Or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://www.iff.com//20240111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "terseLabel": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.iff.com//20240111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.iff.com//20240111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.iff.com//20240111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address State Or Province",
        "terseLabel": "Entity Address State Or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.iff.com//20240111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.iff.com//20240111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.iff.com//20240111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.iff.com//20240111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.iff.com//20240111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "iff_A1.800SeniorNotesDue2026Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20240111",
     "localname": "A1.800SeniorNotesDue2026Member",
     "presentation": [
      "http://www.iff.com//20240111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "1.800% Senior Notes Due 2026 [Member]",
        "terseLabel": "1.800% Senior Notes due 2026 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherAddressMember",
     "presentation": [
      "http://www.iff.com//20240111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Address [Member]",
        "terseLabel": "Other Address [Member]",
        "documentation": "Other address for entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.iff.com//20240111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Postal Zip Code",
        "terseLabel": "Entity Address Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitiesTable",
     "presentation": [
      "http://www.iff.com//20240111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]",
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.iff.com//20240111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.iff.com//20240111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Address Line 1",
        "terseLabel": "Entity Address Address Line 1",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.iff.com//20240111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.iff.com//20240111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.iff.com//20240111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.iff.com//20240111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.iff.com//20240111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInformationLineItems",
     "presentation": [
      "http://www.iff.com//20240111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.iff.com//20240111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "iff_A1.750SeniorNotesDue2024Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.iff.com/20240111",
     "localname": "A1.750SeniorNotesDue2024Member",
     "presentation": [
      "http://www.iff.com//20240111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "1.750% Senior Notes Due 2024 [Member]",
        "terseLabel": "1.750% Senior Notes due 2024 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.iff.com//20240111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.iff.com//20240111/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001193125-24-006619-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-24-006619-xbrl.zip
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ME?:OI>#+'K/I28I*^](';.ZF8VC:"Y[IL-.WR:LK\X2 DFQF?-E+<PX<#I@
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M 7V]%D180>0J1YY:Z8S9*J#/+K:(7T)_)S$+& *3OR.P&0,52^@+NC"^@*C
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MHNM?T=!S'.S[*#K)"E>?$_@>\QB$#_<=,SK&UZQ<.<(6?2M^92KY5_D<LFL
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MW,0N7MB\8CL.JN+P,QQQKS!ADTP<"]EA*IBO&4A2IN..W3C]T<KW&'Z/SD
M4_#3OD;U/)#%IR@%#'T:-F36%^"=GA_4:0-)RD4FQ0+HZ&;:<OI?NX:@56C>
M/SQ_J$_5<%#;F FJ)2\#''.+ H',O 92H24L*1@+EH4M:ZF=XL:7+CBYQWSD
MF#$)2K:163Y'Y;#37S/GF^;+8[SUK!E0_2HD&AQSW4IB(AMF6)2O#"_LZ6AN
M3Y;.BT,9> \-Y7>UV#BS6>]XPB7M_7Z=O+KEEHY_NUU)'"'FYB-28:HH:%3L
MP(=RFMBZ!YV'S=VJ$Q-?'PX<?0_8<[E<>0@]B)E/A?QH?Z&CI79#%8<4JJ N
MORT7*&BUG[R!7:-N@BP/B8:*CW$B)N<MX([\0%!:4M8O.",BZ-0X0?6\+8*.
M,/U0I#TSOI] DPY!<"V<\2:/S([BT,"RK6SH?//>>Z(,UX:4"7OZ=3DQN<SO
M\MJ'T<A0Q)UO]JC')YNQ(9NL[J$9V3_1[$4OZYH"]^%6,QV^WMI-X2]N=(7N
M'&8UM8-53LL(N['G02,*P9!9[US_&=10:Z ),O.:S*C&Y-U/#3BMR<4G]9$S
MH(F:ILC_I[ B8!AD:3:EN'ZJ!\^^-K>N!W:IO&2C(U"Y/*7(,:TVE:L]V]ZD
M2TD+(\PG,Z8\Y<EB&D&&#D0,J' .O>@4(A.YO"I9R!2(\!I.)<)UXQ]N,WA=
M]=4S.@-.[E:2\.N!X<&NZG? VDL=+/FHG1W0^6G^!7K;L!"R+A<*L7E47BN_
MD:WM59U1<0R*6BH!UGX+,I&YH[TRO=JU,OTW(2%I@M+9L>$@(<#SSI[I)F\.
M G3_/MP#MS?MUT!OFQ&H1R;=3L%.75:9:A#%R$F#\A@]=N%:J^]KY=&3?U/G
M-:@\.#E%7D2>5DG@ @_+:<M;YQY+:CJ]'6N$G% 9B;A-O7-NGULY&S:,2]Q^
M*J5N:1* [AQM:@_#F1(Z)V'#+-$MN'KQPTG\37'?O6)@4-\PN8^C;&MXA=C@
MVJ+VB-\A=JIM)K\<)6 1FD=-SKE:45U)4""+S7X1KNBFY]K23BZRX2Q)X:SF
M(YM:"%R7LN/GH6=E]C[96IRLQM:"A&4NINI?<[ E%PVQS 0@AKH5H['A>B)<
MX(Y  G6]#"QTG.(1]D^SSQIK!]H:=I[^!',FI8(0DS1F&*,N2M'I0UD@+Y=2
MQ,0WPP@2*D"ZH0A@W:18/"N,"[GN?CT8BN:I2];QI2V.S@C0 C\F;Y+N5D/?
M-^6TS/G/J8P[55+M(Q=C'" %N7T+@']DM#OS\CK6,>H&BY88; .K=:C(B_-D
MU'1>9%C1C\4]#8>^8 I4](]@&UCJ,\7>/*@+D^CB6] YER9-$HOE2]7MI>Y:
M3!W&M>%%U?((C2?*GQ,SPQTA:N*Z%%,OJBLZI,U'6"Z(UIU#[!$?D; NBM+]
MBB1?T7*B?R$S2P[Z@>2/,C&E6G#T]F0:#IRF3.M3DPQ\AU?0:S+GJ=P2",QF
M/U0F_[=N:T$3\/TDF" @C,5WA>H25Z)I>IC6PW@^S+5:4.BB?M?V=^ZX(:S7
M./_\2,RZ_"QO1<6$6LLIC?_4*1WR#7:$=*3<#,[.19M<PUTXI=TF H&NUXZK
MU3-B@A=X(L"%UXH]5V5EFQE&O&*6Y5G'G&!M9)537N@XW$SBF,X?UCB*MF0Z
MJ&0>#JSOR_0_Y:IO6GO.?@R5$@T^0[1O;1/CF4./JT!C;6UZ.J?C\8'R+5]!
MDTQAOT!4LK"#V:XPC=>^D#R[E&>]=O5,\DN0Z\*A3-PXYF^4M83)I&Y/27HW
M52:1E6(K"9FFYJ3IUW-)0_VDU%)?Z-&&LV[4US&_L<F;I;N)<BI*R7H1&F1U
MN!?(H@OWLK<K=$A!K=!SCP"P%@_0Y"Y(!J_M-(M>+*YUH\9-.KW(AOKP<HWC
M"]-OPN2Y;L:1?V\0FN454!D=&3R DA-%J\XQ(:PE,AQ#7HD>:\(LUF[K^V%N
M(7=;;^JL@99$[$JX\((D[SE+7J?=W;-NS?]<Y6DD05*6H,,!U6'D'.?-E5,V
MI//-S&*Z(IZ$#!Y9*S0XON5=A*-_$6V-Y(B32(=?M_;T%Y;\IURU%03UXKZH
M'EOLI&S*WO>KX;&DZF*86ZH -#+#(XW,4.;<&];C/3@3*V;IF28ED))^>R2O
M"%ZJ9-C:#R9,L#->+-/7(&2;:TE*XSVH%;6BQ^[MR37FJ-G[;!R_ZQ -:8<9
M)4%^)<.!?A276-BJO"#<R#_K%=@T80L*Y'&>(,[E:8?&Q:=WA<;<RIT> ;F,
M4M@-)]@YV7@R0P,&PE/%9 -978Q6%UI,=5YA%UN:YVK4#LGO\*;EWAE'4H'G
MYG!)^A\6!]QK'^4O<,^>4P2M$3LO\,[>0&6]SI@;7XFM0>ON6^_FM6$7#?7+
M_HM]-.P^)$@WQ^%"3KG_1A[\V5=X\ DCN5'?@CJPQ8W$'@7QAI#!&F[Y>MMM
M[_',Q=]TR[^J*P063_A+AB Q=M8NZHBAK2]X:N0^]+\?19K&J&>J:2L2+%H.
MH9=8@;5^SXT?1VO!TF/)6J.6JZX$Q7P?CD"R7FY"!0;+4X#/K&=#U#7);C)U
MVE:Z8 333U#D9$&MF5M7X:)M!,\$KTTW@GDYN*2A(^YVR' ;@:<\Z>A#3':I
MSU7K*R8&'HE)/R('S5*H(LPNU. Y+NJS<0=&W/*-/(*&JV"UA84JG'+!^TU
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MT( "&@HJ%Z+#DKV"55C4-%!6Y_M6,S"GN!W#!W^JP(PC!O\$J8;'\RYQC63
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MJ3(O<7R*H07B"MPS1H-P7%2Y 7#(((BC$@DOHZ_!5*MII&GD,!BK* .BBX^
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M-*I7R7(TZUMB8Q:R4M;%['>TJ"FH5 0#1_'02QBG#D!S*L1(8< [TA04!@S
MZ *"*+);]WN30B,FG")U$V,NG&-8KQ5V*P?YHTP191@G4*Q0G.G@M'7ZB:S-
MJF'VQ0%)&.>CG("T4E( /!JDO\8*GA;AZ)Z270<ENQ,ASH?*7OXYPM6)Y)0,
M(1>3Y  OP,12$7M+^SUK=R$1&XU7GP='@V 'Q&(#M"^H)Q?=CT8;P\^L1 8?
MD XQZCQ'-'46NS!("+T_Q64Q5)H?V7Q!4=4;S,HG40*WA,ALP(X1&],!=*)
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M8Q!D1*BJ=P5AP>@FF'%1X-G%8(7H3S)55,M&<W$VUDJ.%Y;2G!; Y[F ^8X
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M8;?^&U7 V30<7KMDTR X+H"3&>3L8ILL],P/<:6H&ENSK*'W$]>P%CG8P<H
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M'&+)[DI1:!T3QF.TTU3 @@[]Z#U'_4^JE.4<5!JK[(3<E* < G&ME%2/9U]
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M6@!)MU+4GFH/43%<E:"-JU&.R-+'=@. KGWP*Q<W1>\ABC]SS>*(];NVA"(
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M04^D:2 $?P(1+*V[A8BQ;<)2SP5D:8+V0==,GIM[A,$)L+8\=,)8$MH)B W
MW%-K9A3K(6L1.6N7/&>'^XL,C'77/]L1CP1!:B]FD*5.[8+9H4,-"NMHEF9/
M].Z=JMF/M\MU(W2*%D(+TM1S)J,R91/M!*A@(4R>"SC56IT6,3=!)]P@\VYN
M1M+/@@*+9V)7#^LQV9/7[\&X4U62:R\D!*'#@$&PM:.<&% .A)EM8BS[4_L*
MXB;DZF*C"]E]+KTQ(E^@"027#[]ER<!F:@! -!6'5-G]<'VS)M$7)<$].3<.
MRE2I2+DH1F(UP4<XN,B0''4.CG<#: TT'DLG&0,59N1\TB02L0([<?&TGH6C
M7H&#VWKU:+.0DP-W13.C)W9YC1L]AF]B["N#$PC'EPO=@>N#^O(7V%M&87<Z
M&(.:5DK'3>PL0Z8X#!U'5)2^M7"54 #2HB[CL6('%?=^+2#@.>%+XO.D8''2
MB.@E;)'"X-H8.<^[PPX0I2Y NQJU<,<N<W"N"1&<2H5GQW)5]Q!-(H1.;TNH
M"+^<^9%54U--456VYXZK$EFX;L C_A9!S>F,3Q\%.U0L,7T)C8O8S)Q?PJ9P
MS<Y:]2GE!5EL6E$HJ:F;3WF**<N9$J$F"CMC N%;]UB.,)J*C"L(@#6+1([K
MT*G%.AVBC(?IWP//_=_-C9S-G7<4_3,PT2+-)2132\Z[Z-Q$M).T'("( @B:
MSBS<3'2OU:XTVP*+?ZF=;?R'G'98GPO\794LQTZ*1.%EG#M0_[3LR=<^,1'\
M;>Z6Q:>">_/:O9S83H$HU]NW$6L!-!UA+*2GXR FG^AH,N^S<PMMN!0OZS]T
M:A8V/F)XR827I4 SI2]0I%,C1C!3#3TC>PVX/2;>'Z69.U=Y_?F^D>#-2JN/
M;Z>T:H/XV50!USIR#:R!(L6(AIE*3IC@SQM&N$<6Z:MXC\ZW_?=[7T#.T2@\
MN<S6'#;>RLH4$6/591?L"P "64G-F+X2Z3)()TC<(^KM)[[E<3HUM=G=A1\(
M;Z,(!!L"U"70A%;X=HY%Z[0A7SU2-DQJ))BLY!+;!K*589<:-49$\2;'0 61
MKD&6\7E]6DKC6<J7#(!ZP!Z.(SVQH15D/V4_$;6C<21,>X<5V\.RSKY65T/7
M"U:3RDH#CR/3:9JPC)S&$E\,D1#XQJT9AUO,$GC3L&"%>(N0TMO0\4ZX[X.7
M?KC@)8R67L8T>T2=EDN;T"H5\]NZ<F<4)6(IM<DEO4DRO,LS^&FV-L)68ZN;
MC\]KVNGUZ5PHMC><HPO]6O?8?1%V;SSZ=G::WD+T-HRV*!^#<J/0/((9PZ'@
M4$C./6Z-2A1W!$17S"\:76_P&*F>:3[**O:V$M&O^9L+8<7H"M ANN)BK)L2
MOCE#43.IRTI0PW*X#-DI^G<WF_?@''1?W99'&P&V(ZLIKKZQ/UMH5'X"*&"#
M3-!V;:5](TR.?+#W$N?-WI';>$FN ?-))++R74B*/G5-KEWOC(4L>YV-BPF]
M2N8]*_/<1QO^<-&&V$N*510@TV6'\7UQ6@:BSS(\/V*Y.<J*'"-4=-.XSE31
M6A?PV5-QRI%-C&"(!3PC<=FH31@'A(W=L%A\82 TM:E&D+QT">1#&&5!KE-+
ME4%F$@#%=N"4 X[DHP=Q:89"=4X4A\B@EE1E)1NU0@HB=E-&-K@[E*#PD'RD
M<3KET*$B_C(NLL2_N,593ME:P')2QW)F09W=TN9SH@["1L")5R.LKJ')UZRR
MC-T9#SG^"?2/8461Q\[V2%%Q;(*2K?=W&_:2NYI3P+CWL.&<,B\B&E>]FOH
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MS]L5],*@>X;$0&=4LRR#"RZUK8M2.!3KG2Q8YK^C&,9\93@9OIB"BD/U%2<
M_B3%>L5I6<>>A5:P,]500M:&8EQ8,+[E6U3!R5!]L;+NYD4U9T@3$%#QRT4C
MH=HC[UL7HL0+G=)B\Y;]M9%(M;'.6;2L^2VNIQB9;R>8W(I+EG2M-/,.AG'
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M<MO<+P;N%_N':A6A/60R(U4XTHIW3O>#[,<O#61_R L_3IE(2[&16 VN/?J
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M%0.^ZO]OKI_K%_WW0_7D/U!+ P04    " "0@BM8@S?+ZF<(  #'8   %
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M,3(S-S9D.&LN:'1M4$L! A0#%     @ D((K6/6V1W6]2   43X! !$
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M+3(P,C0P,3$Q7VQA8BYX;6Q02P$"% ,4    " "0@BM8H^JSVKD%   $/0
M%               @ &<JP  :69F+3(P,C0P,3$Q7W!R92YX;6Q02P4&
/  < !P"^ 0  A[$

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
